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Abstract 
Background: Nursing homes face challenges in the coming years due to the increased 
number of elderly. A new law in force from Jan 2012 (“Samhandlingsreformen”) places more 
responsibilities on the counties running the nursing homes. Quality will come under pressure, 
expectations of services will rise and clinical complexity will grow. New strategies are needed 
to meet this situation. Modern clinical information systems with decision-making support may 
be part of that. In addition, knowledge about the prevalence of clinical conditions among 
long-term patients in nursing homes is poor, and research on this population is needed. 
Objectives: We wished to define the clinical and practical parameters needing to be improved 
among long-term patients in nursing homes, which could then be used as endpoints in an 
intervention study. 
We then wanted to test if a structured electronic medical record system with decision-making 
support improved the quality of the endpoints. 
Methods: First we performed a literature search study on structured medical records. We then 
developed a full-scale, semi-structured, interdisciplinary electronic medical record system 
with extensive decision support options and conducted four studies, three to define endpoints 
and gain medical knowledge about the nursing home population: “Hospitalizations from 
nursing homes”, “Psychoactive drugs in 7 nursing homes” and “Atrial fibrillation and heart 
failure in nursing homes”. Then we performed an intervention study, “Can electronic tools 
improve nursing home quality?” 
Results: Installing the information system in seven new nursing homes proved easier than 
expected. After four months’ training the nursing homes switched to the new system and used 
it as the only medical record system on a daily basis for the next 12 months (February 2008 – 
February 2009). 
We discovered a seriously low warfarin treatment rate (14%) to patients with atrial fibrillation 
(N = 90), considerable treatment rate differences between institutions regarding use of 
neuroleptics (18 – 55%) and the proportion of patients not weighed for the last 30 days was 
72.6%. 
The proportion of patients taking neuroleptics was reduced from 33.0% to 21.5% (N = 183 
before/205 after, chi-square test, p = 0.015), i.e. a difference of 11.5% (95% CI: 2.3 to 
20.6%). Warfarin increased from 3.0% to 9.8% (p = 0.013), i.e. a difference of 6.8% (95% CI: 
1.6 to 12.1%). The internal controls did not change: use of digitoxin did not increase 
significantly (8.0% vs. 8.5%; p = 0.1), thyroxin was not reduced (10.0% vs. 8.6%, p = 0.765) 
and antidiabetics did not increase (10.0% vs. 10.5%; p = 0.996). The proportion of patients 
not weighed for the last 30 days was reduced from 72.6% to 16.0% (p < 0.001), i.e. a 
difference of 56.6% (95% (CI: 47.5 to 64.5%)). 
Conclusions: There exist treatment differences among nursing homes. Research showing 
consequences for patients is pending. The electronic medical record system with integrated 
decision-making support may be a way to improve quality. The present material is too small 
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for firm conclusions however. The application should be tested in multiple medical settings, 
and may provide a route from pure economic to more scientific healthcare governance, as 
management data can be produced through daily work without time-consuming and costly 
additional projects and can be monitored electronically on a continuous basis. This may have 
relevance to New Public Management, which so far have had shortcomings regarding valid 
quality parameters. We introduce the idea of "health administration through structured 
records" (HATS). 
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Expressions and abbreviations 
ACEI Angiotensin-converting enzyme inhibitors 
AF Atrial fibrillation 
ANOVA Two-way analysis of variance 
ARB Angiotensin receptor blockers 
ATC The anatomical therapeutic chemical classification system 
BP Blood pressure 
CHADS2 Prediction rule for estimating the risk of stroke in patients with atrial fibrillation 
CI Confidence interval 
DDD Defined daily dosage 
DEG Digital era governance 
DRG Diagnosis-related group system 
ECG Electrocardiogram 
eGFR Estimated glomerular filtration rate 
GP General practitioner 
HATS Health administration through structured records 
ICD-10 International statistical classification of diseases 
ICT Information and communication technology 
IPLOS Norwegian national system for care statistics 
IT Information technology 
NPM New public management 
NT-proBNP N-terminal prohormone of brain natriuretic peptide 
OR Odds ratio 
PCIS Patient care information system 
QI Quality indicator 
sEPR Structured electronic patient record 
WHOCC WHO Collaborating Centre for Drug Statistics 
 
(www.wikipedia.com): 
“Warfarin (also known under the brand names Coumadin, Jantoven, Marevan, Lawarin, 
Waran, and Warfant) is an anticoagulant. It is most likely to be the drug popularly referred to 
as a "blood thinner," yet this is a misnomer, since it does not affect the thickness or viscosity 
of blood. Instead, it acts on the liver to decrease the quantity of a few key proteins in blood 
that allow blood to clot”. 
“Atrial fibrillation (AF) is the most common cardiac arrhythmia (irregular heart beat). It may 
cause no symptoms, but it is often associated with palpitations, fainting, chest pain, or 
congestive heart failure. AF increases the risk of stroke; the degree of stroke risk can be up to 
seven times that of the average population, depending on the presence of additional risk 
factors (such as high blood pressure). It may be identified clinically when taking a pulse, and 
the presence of AF can be confirmed with an electrocardiogram (ECG ) which demonstrates 
the absence of P waves together with an irregular ventricular rate. In AF, the normal regular 
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electrical impulses generated by the sinoatrial node are overwhelmed by disorganized 
electrical impulses usually originating in the roots of the pulmonary veins, leading to irregular 
conduction of impulses to the ventricles which generate the heartbeat”. 
“An antipsychotic (or neuroleptic) is a tranquilizing psychiatric medication primarily used 
to manage psychosis (including delusions or hallucinations, as well as disordered thought), 
particularly in schizophrenia and bipolar disorder. A first generation of antipsychotics, known 
as typical antipsychotics, was discovered in the 1950s. Most of the drugs in the second 
generation, known as atypical antipsychotics, have been developed more recently. A number 
of harmful and undesired (adverse) effects have been observed, including lowered life 
expectancy”.  Neuroleptics are contraindicated to patients with Parkinsonism as they create 
Parkinson symptoms. 
“ACE inhibitors or angiotensin-converting enzyme inhibitors are a group of drugs used 
primarily for the treatment of hypertension (high blood pressure) and congestive heart failure. 
Originally synthesized from compounds found in pit viper venom, they inhibit angiotensin-
converting enzyme (a component of the blood pressure-regulating renin-angiotensin system), 
thereby decreasing the tension of blood vessels and blood volume, and in turn lowering blood 
pressure”.  
“Angiotensin II receptor antagonists, also known as angiotensin receptor blockers 
(ARBs), AT1-receptor antagonists, are a group of pharmaceuticals which modulate the 
renin-angiotensin-aldosterone system. Their main uses are in the treatment of hypertension 
(high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive 
heart failure”. 
“The N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is a 76 amino 
acid N-terminal fragment of brain natriuretic peptide. Both BNP and NT-proBNP levels in the 
blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be 
useful to establish prognosis in heart failure, as both markers are typically higher in patients 
with worse outcome. The plasma concentrations of both BNP and NT-proBNP are also 
typically increased in patients with asymptomatic or symptomatic left ventricular 
dysfunction”. 
In medicine, comorbidity is either the presence of one or more disorders (or diseases) in 
addition to a primary disease or disorder, or the effect of such additional disorders or diseases. 
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“A benzodiazepine is a psychoactive drug whose core chemical structure is the fusion of a 
benzene ring and a diazepine ring. The first benzodiazepine, chlordiazepoxide (Librium), was 
discovered accidentally by Leo Sternbach in 1955, and made available in 1960 by Hoffmann–
La Roche, which has also marketed diazepam (Valium) since 1963. Benzodiazepines enhance 
the effect of the neurotransmitter gamma-aminobutyric acid (GABA), which results in 
sedative, hypnotic (sleep-inducing), anxiolytic (anti-anxiety), anticonvulsant, muscle relaxant 
and amnesic action. These properties make benzodiazepines useful in treating anxiety, 
insomnia, agitation, seizures, muscle spasms, alcohol withdrawal and as a premedication for 
medical or dental procedures”. 
“The Anatomical Therapeutic Chemical (ATC) Classification System is used for the 
classification of drugs. It is controlled by the WHO Collaborating Centre for Drug Statistics 
Methodology (WHOCC), and was first published in 1976. The classification system divides 
drugs into different groups according to the organ or system on which they act and/or their 
therapeutic and chemical characteristics. Each bottom-level ATC code stands for a 
pharmaceutically used substance in a single indication (or use)”.  
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Can a structured electronic medical record with decision-making support 
improve nursing home quality? 
Introduction 
We have defined the prevalence of several medical conditions, mistreatments and procedures 
in nursing homes and then examined if an electronic medical record system with decision 
support improved quality. 
This work can be viewed from multiple angles. 
It may be regarded as a standard clinical work which seeks information about clinical 
conditions in a nursing home population. Little research has been accomplished attempting to 
determine what distinguish this population from other populations of elderly. Patients above 
75 are often excluded from regular clinical trials. Even the simplest counts and surveys are 
therefore needed as a basis for future research.  
Another perspective is the technological. Is it possible to construct a basic dataset and a 
structured electronic medical record system that covers all documentation needs in nursing 
homes? To what extent then, are doctors and nurses satisfied with the tool in their daily 
patient-related work? Would reminders, based on automatic procedures, be able to change 
treatment practice? 
Then there is the administrative perspective. Is there a connection between modern electronic 
medical records and healthcare governance? Can a structured electronic infrastructure in 
healthcare improve the creation of valid quality and production parameters, and through this, 
impact motivation, production and quality in a positive way which was not possible by 
traditional New Public Management methods? 
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Background 
Norway has 4.98 million inhabitants (January 2012), 55 public hospitals, 41,052 nursing 
home beds and 1,796 beds in old people’s homes. 96.8% of nursing home beds are in single 
rooms and 43.3% of all deaths (41,342 in total) are in nursing institutions [1]. The healthcare 
system is split into first and second line services. The second line contains the 55 hospitals 
and specialist services (including private specialists). The second line is administered and 
financed directly by the state. First line services are administered and financed by the 
municipalities (N = 431). The first line covers general practice (GP) services, mother and 
child care, home-care and nursing homes (N = 900). 
It is expected that nursing homes will play an important role in healthcare delivery in the 
years ahead. The population is growing older and patients admitted to hospitals are being 
discharged earlier. A Norwegian white paper states that reform is needed to the collaboration 
between primary care and hospitals [2]. The growth in costs and utilization of hospitals is not 
sustainable. Among several proposals, the white paper points to accomplishments involving 
early discharges from hospitals to nursing homes which offer structured rehabilitation 
programmes. Quality will thus be under pressure, expectations of services will rise and 
clinical complexity will grow. New strategies are needed to meet this situation. Modern 
clinical information systems with decision-making support may be part of that. 
Bergen had 250,000 (2006)  inhabitants and 32 (35, 2012) nursing homes (2,300 beds). The 
number of beds ranges from 20 to 189 per institution. As of January 2013, the municipality 
had a population of 267.900. 
Quality improvement strategies in general 
Documenting quality status and improving quality in nursing homes is a challenge. 
Internationally, several quality improvement studies have been undertaken: Nursing homes 
with a smaller number of beds, operating for profit and having a high level of nursing staff 
may improve quality [3]. It has been claimed that marginalization of physicians in the nursing 
home threatens the overall care of increasingly frail nursing home residents who have 
medically complex illnesses [4]. Medication quality improvement efforts in nursing homes 
should probably focus on the medications commonly implicated in errors and should continue 
to discourage or closely monitor the use of medications considered potentially inappropriate 
in the elderly [5]. A menu-driven incident-reporting system has the potential to enhance 
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quality improvement efforts in nursing homes [6]. In pain management a multifaceted 
collaborative intervention proved valuable, involving audit and feedback on pain 
management, education, training, coaching using rapid-cycle quality improvement techniques, 
and inter-nursing-home collaboration [7]. There has even been shown to be a relationship 
between ambitious targets and nursing home quality [8]. Implementing small, focused and 
inexpensive interventions, like monitoring blood pressure (BP) controls, can improve quality 
[9]. Structured drug audit has been tested in nursing homes in Bergen and it reduced drug 
related problems [10]. 
Simply providing comparative performance feedback may not be enough to improve resident 
outcomes [11]. Targeting specific drugs in the surveyor's interpretative guidelines as a method 
of reducing potentially inappropriate medication use does not produce the desired gains in 
terms of improving the quality of medication use either [12].  
It is difficult to envisage adequate quality control without the use of modern technology like 
medical record systems with alarms, statistics and decision-making support in addition to 
already proven tools for improving the quality of drug use. The effectiveness of decision 
support tools has been shown in several studies and should be tested in nursing homes [13, 
14]. 
Structured electronic medical records 
Norwegian authorities have revealed weaknesses in the record systems at nursing homes 
during a number of inspections and these issues are addressed in several reports: 
 “The Norwegian Board of Health Supervision takes very seriously what has been 
presented in terms of record systems and quality of records at the nursing homes. This 
applies both to the widespread lack of efficient record systems for all employees, the 
lack of systematic approach to what is being recorded, and a widespread lack of 
documentation for important and relevant information about patient medication” [15]. 
 “There seems to be a need for central authorities to invest heavily to develop an 
adequate electronic documentation system with comprehensive medical records that 
are user friendly for all healthcare professionals in nursing homes” [16]. 
The technical developments and medical studies performed during this project are thus in line 
with needs in the nursing and care sector and with public plans. 
  Page 14 
 
  
Structuring medical information may be a prerequisite to success when it comes to developing 
adequate and modern medical record systems [17, 18]. To our knowledge, however, few full-
scale structured medical record systems have yet been developed in Europe, and scientific 
testing for improvements in the quality of full-scale medical record systems is still pending. 
After the initial, innovative decade with electronic patient records, the international medical 
community began to concentrate on future gains from using electronic patient records [19], 
enhanced efficiency, less error, better cost control, and improved therapeutic regimes and 
organizations as a result of database analyses.  
American authorities defined a number of particularly important factors at the time of an 
attempted healthcare reform in the USA in the early 1990s [20]. Central to this was the motto 
of “Getting the right information to the right person at the right time”. In order to achieve this 
and other objectives, attention was to be directed towards a number of aspects in particular: 
use of standard forms and standardized data definitions, a nationwide electronic healthcare 
network, data capture from the day-to-day healthcare work, widespread use of electronic 
patient records and database analyses for continuous quality enhancements and patient 
involvement. Such objectives and methods are also key to Norwegian plans [21-25], but the 
gains envisioned have yet to materialize. Use of information technology (IT) in the health 
services has not yielded the professional gains and benefits expected. One important 
prerequisite for achieving such gains may be to structure the electronic record notes. Are there 
any research-based grounds for this? 
In order to accommodate the growing complexity and pressures of modern medicine, we need 
tools for rational documentation and quality control [30]. Although there are many 
components in place to achieve such objectives, such as a secure healthcare network, 
reporting standards and widespread use of electronic patient records, it can be difficult to 
achieve the aims of effective quality assurance tools without targeted structuring of segments 
of the body of medical information. This structuring can be done by developing basic data 
sets for the most important clinical situations within each specialty. It is probably unrealistic 
to think that free-text search methods can be developed to such a level that necessary data can 
be obtained with satisfactory quality. Great expectations attach to the possibilities that open 
up for presenting medical knowledge on doctors’ computer screens, either as freestanding 
reference works or as integrated control functions in an electronic record system. The reason 
  Page 15 
 
  
there have been problems with the implementation of such arrangements is a lack of structure 
in the basic information to which such systems need to respond. 
The opposite of structured (or semi-structured) patient records is free-text records. In a free-
text system “blood pressure” will be recorded as written; "BP: 120/80" or as "blood pressure 
120:80" or in any one of about 30 other ways of recording blood pressure in free-text. 
Most record systems on the market do not have the option of recording medical data in a 
standardized, structured fashion. In structured systems, recording is done in predefined fields: 
“BP_syst” and “BP_diast”, and the new values are always added to the same data register. 
The structured way of recording parameters opens up the possibility of making graphs, alarms 
(e.g. “if blood pressure is below a defined value, then pop up an alarm”) and population filters 
(e.g. “if patient blood pressure is above a certain value, then put on a list together with similar 
patients”). Figure 1 demonstrates a structured form.  
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Figure 1. Demonstrates a ”nursing load form” of the structured medical record system. Instead of 
free-text the different parameters are predefined. It is important for the practical daily work that the 
forms can be presented in different ways; as forms (above), as worksheets (convenient for test) and as 
concatenated text (as part of the total chronological record). This switch among different ways to 
present content is done by clicking the tabs at the bottom of the form. By hocking the field 
“Kommentarer/fritekst” a field for adding free-text opens. 
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Figure 2 below and figure 2, publication 4  demonstrate how alarms are presented to the 
user from within the patient record, and figure 3 below and figure 1, publication 4 
demonstrate practical use of population filters/lists. 
 
 
Figure 2. Demonstrates how alarms are presented. Different categories of alarms exist; interactions 
(DRUID interaction database is part of the system and scans all medication lists continuously), 
conflicts with the administrative procedures (e.g. “not weighed last 30 days”), more complicated 
clinical alarms (e.g. “the patient is using several antihypertensives but systolic blood pressure is 
below 110”), planned time stamps (e.g. “it is time for a new B-12 injection”) or logical inconsistency 
between drug list and the list of diagnoses (e.g. “the patient is using insulin but does not have the 
diagnosis diabetes, would you like to add?”). 
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Details of population filters 
 
Figure 3. Demonstrates the practical use of population filters. If you need to know which patients are 
on antibiotics at the moment you; step 1 – click on the population tab of the patient list (all patients in 
this institution), step 2 – choose one of the predefined medication filters (“antibiotics”) and step 3 –  
the list of patients on antibiotics is presented. Several patient filters within different categories are 
available, also filters based on complex criteria (e.g. “patients with a diagnosis of atrial fibrillation 
without any antihrombotic medication”). 
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Structured record and basic clinical data set 
Recording data by means of structured form is faster, and the content satisfies the needs of a 
normal medical record [26]. In a Swedish study of 300 general practitioners (GPs), it was 
found that even in a busy general practice the doctors found the workload imposed by 
structured recording acceptable. In a large-scale EU project an electronic system (KNAVE-II) 
was used to fill in sometimes complex, structured forms, and completion was done as part of 
the everyday clinical routine. Use of time and user satisfaction was better with electronic, 
structured data capture/record-keeping than with manual systems [27]. On the face of it, it 
may seem sensible to mix structured data in the record with the option of free-text recording 
in order to increase flexibility for the users [28]. Aabakken and colleagues at Ullevål 
University Hospital discovered this when setting up and evaluating the SADE, a database for 
gastroenterological patients [31, 32]. Research has also shown that details in the design and 
layout of electronic forms can affect how rationally they are used [33, 34]. However, a study 
has shown that free-text comments from the doctors in connection with electronic drug 
prescription alter the opinion content of the structured prescription [29].  
In the case of the electronic free-text record we know that the quality of the data in the 
databases is not good enough for research purposes [30, 31]. The same applies to decision 
support systems. In a geriatric hospital ward a group of researchers studied differences in data 
quality between two patient groups [32]. In one group, the structured record was used, while 
in the other group the traditional record was used. The authors concluded that the data quality 
was considerably better in the group with the structured record and that the improvements 
seemed to be linked to the structured data capture, not to the focused approach that is natural 
when introducing new systems.  
For nurses it has been shown that documentation quality and scope for targeted intervention 
improved on introducing electronic systems with structured nursing documentation [33].  
A number of studies have evaluated electronic forms filled in by patients, especially for 
logging symptoms. In back patients, pain recording with the aid of a small laptop was 
compared with the use of manual questionnaires and phone interviews [34]. Electronic 
recording was entirely valid, and patients preferred this method. By the same token, a similar 
pain form was studied among 60 children aged 8–16 with headaches or juvenile rheumatoid 
arthritis [35]. Both data quality and compliance were better in the group using electronic 
forms. 
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At two urology wards in the USA, nine structured, standardized forms were developed, 
replacing all other medical documentation for both in- and outpatients over a period of time 
[36]. The authors of the study concluded that it is possible to agree on such a basic data set 
among urologists and that the work can form the basis for nationwide use of electronic, 
clinical structured records. 
Decision support 
Decision support is closely correlated with structured record information, because the 
decision support tools have to respond to information in the record – pathological test results, 
for example. This is easier to accomplish if the underlying data are structured. A number of 
major European projects hinge on this issue [37]. There are weaknesses involved in 
introducing consensus-based therapeutic regimes in a population. Often test results are not 
followed up. In a study of an electronic reminder system, the follow-up proportion in the 
intervention and control groups was 46% and 22%, respectively. The intervention consisted of 
an on-screen electronic reminder at the time of ordering the tests or samples [19]. 
In early Norwegian studies it was difficult to prove the effect of such electronic initiatives 
[38, 39]. Part of the explanation may be that patients with the clinical conditions studied 
(hypertension and diabetes) are traditionally given a great degree of ongoing information via 
the pharmaceutical industry and there is thus reduced potential for improvement. Later studies 
have shown positive effects within several fields of therapy. 
The health care organization Kaiser Permanente in Ohio has introduced a comprehensive 
electronic patient record system that supports quality interventions and a number of 
administrative tasks [40]. Cost-benefit analyses have shown that the organization can save 
expenditure that justifies the costs of maintaining the system. Feedback on personal 
prescription practice among GPs is a promising model for general improvement [31]. 
Improvements have also been reported when GPs using the electronic patient record receive 
feedback on the treatment of cardiac and stroke patients [13]. 
In a meta-analysis Kawamoto and colleagues deal with studies on the effectiveness of 
decision support systems [14]. Literature searches were done in Medline, CINAHL and 
Cochrane, choosing studies that showed significant improvement in clinical practice and 
studies that dealt with 15 commonly discussed aspects of such systems. Combined, this gave 
70 different studies. 68% of them showed significant improvement in practice. Multiple 
logistical regression analyses identified four independent factors that increased the probability 
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of a positive result: automatic presentation of decision support information integrated into the 
work process, recommendations rather than directives, advice at the moment the decisions are 
taken and computer-based support.  
Of the 32 systems that met all the criteria for improving practice, 30 brought about some 
improvement in clinical practice. On an experimental basis a positive effect was found from 
periodic feedback, from sharing recommendations with the patients and from demanding 
documentation from anyone not following the recommendations. 
Population-targeted intervention  
The traditional medical approach focuses on the individual, with particular emphasis on 
symptoms, signs and test results emerging from the encounter with individual patients. In 
order to ensure accessible and correct treatment for all patients, it is also possible to operate 
using population-directed control measures.  
At healthcare institutions using electronic patient systems, a database is automatically created 
in which all patient contacts are registered. These databases can contain easy-to-access 
epidemiological data and can represent one option for population-targeted control systems. 
For example, it is possible to find all patients who have received special treatment within a 
given period. Such databases from multiple institutions can be merged to form the basis for 
important evaluations in relation to large, clinical populations [13]. 
Use of standardized, electronic registration on a large scale can have major consequences for 
therapeutic regimes. This has been shown for example in a large study among American 
ophthalmologists [41]. Eight public eye wards with a total of 160 ophthalmologists took part 
in recording individual clinical data on all patients undergoing cataract surgery. The purpose 
was to evaluate the consequences of systematic, structured electronic recording. Evaluating 
the data collected turned out to have an effect on the overall therapeutic regime for the 
patients. The authors concluded that this form of data registration has potential as a continuing 
method of evaluation and should be available nationwide in future. 
The Veterans Health Administration is the largest single supplier of healthcare services for 
HIV-positive people in the USA. Structured patient data have been stored for a number of 
years now, and it has been shown that analyses of the central database affect the therapeutic 
regimes. The central database is currently administered by a national quality assurance 
organization [42]. 
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The benefit of population-targeted intervention has also been proved in several studies. In a 
study with 3,073 patients with hemofec test appointments, the compliance rate was just 18%, 
but increased to 33% with the introduction of a system for sending patients reminder letters 
automatically. The patients were found by searching the database [43]. 
Doctors’ and nurses’ views  
The users’ views on data systems are important for the real-term prospects of spreading such 
tools. In a study on doctors’ views on introducing an electronic record system and a reporting 
system in a large insurance organization in the USA, almost all the doctors thought that the 
electronic patient record brought about improvements in the working situation and patient 
treatment, while some three-quarters saw advantages to the system for reporting results [44]. 
Improvements in coordination of therapeutic measures, opportunities to pinpoint cases of 
mismedication and possibilities for responding to pathological test results with sufficient 
speed were highlighted in particular. 
GPs’ views on their own ability to follow up pathological test results and on any auxiliary 
systems have been examined in an American study with 216 doctors with electronic patient 
records [45]. Of those who replied (65%), less than one third were happy with the current 
systems’ ability to retain an overview of pathological test results, including X-ray results. 
90% wished for automated systems to keep tabs on the pathological test and investigation 
results. 97% believed they could do a better job if they received help from electronic 
reminders. 
Nurses’ views on electronic patient records have been studied at a major hospital in Florida 
[46]. Of 100 nurses, one third felt that electronic patient records resulted in a reduced 
workload, and roughly the same proportion preferred being able to provide documentation at 
the patient’s bedside but said that this was often made difficult. A quarter thought that 
documentation was improved and the use of electronic patient records would improve patient 
safety. Nurses with experience of information technology consistently had more positive 
views than those without such experience. 
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Some clinical issues in nursing homes 
Use of psychoactive drugs and differences between institutions 
There are several good reasons to monitor the use of psychoactive medications in nursing 
homes. The high consumption of psychopharmaceuticals in nursing homes has been 
emphasized in a number of studies and the prevalence of psychoactive drugs has been well 
documented earlier, but some years ago [47-49]. Few authors have placed the emphasis on 
treatment differences between nursing homes and the general differences in medication of 
patients suffering dementia as opposed to non-demented nursing home patients [50-65]. 
Atrial fibrillation and heart failure 
Two of the most frequent diagnoses among the elderly are atrial fibrillation (AF) and 
congestive heart failure. The prevalence of AF has not been studied in Norwegian nursing 
homes, nor has the way AF is treated. The question of under-treatment of heart failure in 
nursing homes has been raised earlier [48]. 
AF is an independent risk factor for developing a stroke [66], and in the elderly it is one of the 
most important causes of stroke [67]. It is important that patients with multiple risk factors for 
embolisms are adequately anticoagulated [68]. The current guidelines state that most patients 
over the age of 75 with atrial fibrillation should be anticoagulated, but increasing age often 
produces the opposite effect [69, 70]. 
It is important to consider stroke risk against bleeding risk when deciding whether or not to 
treat. The relationship between the two factors may be different for the oldest population than 
for younger patients. Stroke risk in AF patients can be estimated using the CHADS2 score 
[71, 72].  
To estimate the risk of bleeding for AF patients on warfarin treatment, bleeding risk scores 
can be used [73]. In the study cited the high-risk bleeding individuals (5.6% bleeding risk) 
had a 7% stroke risk.  
When it comes to methods for diagnosing heart failure, clinicians often wonder to what extent 
proBNP is biased by age, renal failure and weight. 
Weight loss 
The presence of nutritional failure in Norwegian nursing homes has been questioned [74]. 
Little research in the field has been done so far. There is good evidence showing that 
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inappropriate weight loss in the elderly materially impairs their quality of life and life 
prospects. The convalescence period for illness also increases substantially [75]. A 
significantly increased risk has been shown for secondary complications like pressure sores 
[76], infection, depression and functional impairment [77, 78] as well as increased mortality 
[79-83]. The necessity of good weighing routines is therefore obvious. 
Hospitalizations from nursing homes 
Little research has been done on admissions from nursing home to hospital. There are no 
studies in this field from Norway [84]. Internationally, a correlation has been found between 
the lack of documented decisions on the level of treatment and the increase in admission rate 
[85]. Clear documentation in logs and records concerning hospital admissions and heart-lung 
do-not-resuscitate decisions can prevent unnecessary admissions. Acknowledged routines 
currently in place to treat terminal patients (Liverpool Care Pathway) may be important to 
make these decisions easier in nursing homes [86]. We also know that information gaps 
commonly occur when elderly patients are transferred from a nursing home or seniors’ 
residence to the hospital [87]. 
# 
Based on this knowledge we developed a full-scale, interdisciplinary, semi-structured (free-
text AND structured forms) electronic medical record system during the period 2005-2008 
together with the basis dataset (the collection of semi-structured forms) covering 
documentation needs in nursing homes. A collection of electronic alarms (e.g. “the patient has 
not been weighed for the last 30 days”) was also developed together with a collection of 
population filters (e.g. “patients on this list are using neuroleptics”). We planned to test 
scientifically whether decision-making support would bring about quality improvements in 
some clinical (e.g. “percentage patients on neuroleptics”) and practical (e.g. “percentage of 
patients not weighed for last 30 days”) parameters in a before-after study where the 
intervention was full-scale use of the sEPR system in nursing homes.  
After four months’ training the nursing homes switched to the new system and used it as the 
only medical record system on a daily basis for the next 12 months (February 2008 – 
February 2009). 
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Objectives 
Primary objectives 
 To define clinical and practical parameters which need to be improved, and which can be 
used as endpoints in an intervention study, among long term patients in nursing homes. 
 To test if a structured electronic medical record system with decision support improves 
quality of the endpoints. 
Secondary objectives 
 Investigate the incidence of hospitalizations from nursing homes, the major diagnostic 
reasons, what burden these hospitalizations represent for the main hospital departments, 
and what impact manpower and short to long-term bed ratio has. 
 To pinpoint any differences in treatment with psychoactive drugs between participating 
nursing homes, investigate which drugs are currently prescribed most frequently for long-
term patients in nursing homes, estimate prevalence of administration for the following 
drug groups: neuroleptics, antidepressants, antidementia agents, opioids and the 
neuroleptics/anti-Parkinson’s drug combination, and study comorbidity correlations. We 
also wanted to study differences in the administration of medication for patients with 
reduced cognitive functions in relation to patients with normal cognition. 
 To investigate to which degree long-term nursing home residents with AF received 
antithrombotic treatment and to what extent patients with NT-proBNP above 225 pmol/l 
were treated with angiotensin-converting enzyme (ACE) inhibitors/A2 blockers, beta-
blockers, statins and diuretics, and to discuss ProBNP as a diagnostic tool. We also 
wanted to study whether there were differences in treatment between the nursing homes 
and to investigate how often long term patients in nursing homes in Bergen are being 
weighed. 
 To try to find a theoretical link between structured medical records and NPM (New 
Public Management) and thereby connect it to healthcare governance in general. 
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Materials and Methods 
Material and methods of the hospitalization study 
Publication 1. 
During the period March 2006 to March 2007 (12 months) all hospital inpatient admissions 
from nursing homes in the Municipality of Bergen to the primary and referral hospital were 
recorded (the two only hospitals in Bergen). This was done by searching the ambulance 
service’s register of transports from nursing home addresses to the two hospitals. These 
patient transports were then compared with the hospitals’ case history registers to find ward 
and diagnoses (ICD-10) and length of stay. The ambulance register was the only complete 
source to find fairly complete figures on hospitalizations from nursing homes for this 
retrospect study. To search more information about each patient from the hospital records was 
beyond the scope of the study. Calculations are based on the principal diagnosis. Information 
about physician manpower, number of total beds and number of short-term beds was gathered 
from the county health administration. 
Two hospitals are delivering hospital services to the city and surrounding municipalities. 
Bergen population represents 62.5% of the total population served by the hospitals 
(population 400 000).  
There is only one, public, ambulance service in Bergen. Close to 100 percent of admissions 
from nursing homes to the hospitals are done by means of ambulance. By all transports, 
patient name, transport addresses and key medical observations are registered in a database. 
Linear regression analysis was used to relate admission rates for the nursing homes to the 
proportion of short-term beds, and the proportion of explained variation in admission rates 
expressed by the determination coefficient (R
2
). For analyzing data we used Excel and JMP8. 
Material and methods of the prevalence studies 
Publication 2 and 3. 
Bergen has approximately 250,000 inhabitants and 32 nursing homes (2,300 beds), figure 1, 
publication 1. Bed numbers range from 20 to 189. Seven nursing homes participated in this 
study. Participating nursing homes were selected based on a relative similarity of functions, 
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county ownership (no private institutions) and physician staffing. Further nursing home 
characteristics are presented in table 1, publication 2. 
Information about the patients was gathered during the period March-April 2008. Twenty-
four medical students conducted the data collection, which consisted of copying medication 
cards (information about drug names, if regular or as-needed, prescription and dosage), 
weighing by means of local tool, but standardized clothing, finding previously recorded 
weight/date, details of any stroke suffered and degree of cognitive impairment. 
Electrocardiography (ECG) was conducted to diagnose atrial fibrillation and a standardized 
set of blood samples was analyzed (haemoglobin, B-type natriuretic peptide (ProBNP), 
sodium, potassium, calcium, albumin, creatinine, blood urea nitrogen, urate, estimated 
glomerular filtration rate (eGFR)).  
Only long-term patients (N = 513) were included. 447 of the patients were blood-tested and 
484 ECG’ed. 488 of the patients were weighed and it was possible to find the recorded weight 
in 431 patients. It was possible to conclude if the patient had undergone a stroke in 462 of the 
patients and if they were demented or not in 511. Complete medication records existed for all 
patients. 
We used ProBNP > 225 pmol/l as an indicator for patients with probable heart failure. To get 
an impression of the biasing effect of age, weight and renal function in this population, we 
performed bivariate fits of ProBNP by these factors and a multiple linear regression analysis 
of the square root of proBNP on age, weight and the square root of eGFR. We also estimated 
non-parametric correlation (Spearman’s) between ProBNP and eGFR. Linear regression 
analysis was used to examine the dependency of proBNP on age (in years), weight (in kg) and 
renal function (eGFR), and explained variation was quantified by the determination 
coefficient (R²). A multiple linear regression analysis of the square root of proBNP on age, 
weight and the square root of eGFR was performed to get a prediction equation for ProBNP. 
In order to group the material into patients with/without cognitive impairment, we used the 
Berger scale [88] and recorded patient information. A caregiver who knew the patient decided 
between 6 ”level descriptions” of cognitive impairment, thus rating the degree of severity as a 
score from 0 to 6. The method was validated by comparing the extent to which drugs for 
dementia were given to patients scoring above 0, giving a 95% overlap. 
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The recorded data were keyed into Excel and the drugs coded according to the Anatomical 
Therapeutic Chemical (ATC) Drug Register [89]. For each drug the students punched in the 
full ATC code, dosage, number of times per day given, total daily dosage and whether 
regular/as-needed. For the psychoactive drugs which are part of the comparison between 
institutions, Defined Daily Dosages (DDDs) were registered (except for opioids being part of 
kodine/paracetamol combination drugs). To compare the total use of psychoactive drugs 
(hypnotics, anxiolytics, anti-dementia drugs, neuroleptics and opioids) between institutions, 
we used the calculated parameter; [(Drug DDD) x (% of patients in institution on drugs of 
drug-class)].  
Straight counts were performed in Excel, but for statistical analyses JMP version 8 (from 
SAS),  was generally used. Means and standard deviations (SD) are reported. To analyze 
differences in the average between multiple groups for continuous data, the Tukey-Kramer 
(Honestly Significant Difference) multiple comparison procedure was used as a parametric 
method (Clyde & Kramer, 1956; Ramsey, Ramsey & Barrera, 2010) and the Kruskal-Wallis 
analysis of variance as a non-parametric method. For analyzing ordinal and nominal data, the 
Pearson chi-square test was used and the results reported as odds ratios (OR) with 95% 
confidence intervals (CIs). All tests were done at significance level 0.05. To search for factors 
with potential impact on prescription rates we conducted a multinomial logistic regression 
analysis, and to adjust for differences in patient and nursing home characteristics we 
performed a two-way analysis of variance (ANOVA). 
Material and methods of the sales statistics analysis 
In addition we also analysed the sales statistics for 2011. An Excel file from the vendor 
contained all orders per institution (private and public), with drug names, amounts, ATC-
codes and defined daily dosages. We performed this analysis to see if results from the 
prevalence studies, which showed considerable prescription differences between institutions, 
could be confirmed by using a different method to shed light on the question. All drug orders 
for the year 2011 from all nursing homes in Bergen (N 35) were analyzed. For all institutions 
the total yearly order was the sum of multiple (36-102) part orders, which indicates by need 
ordering, which again indicates that storing is probably not a considerable biasing factor. 
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Material and methods of the intervention study 
Publication 4. 
Based on information from the prevalence studies described above we decided to test the 
following endpoints; 1) the proportion of long-term patients with atrial fibrillation that were 
being given warfarin, 2) the proportion of long-term patients taking neuroleptics and 3) the 
proportion of long-term patients not weighed for the last 30 days. To perform this, a before-
after intervention study was done. The before-after study was conducted as a double cross-
sectional design. Instead of randomization, we decided to use the proportion of patients on 
digitalis, thyroxin and antidiabetics as internal controls (participants exposed to the same 
study, but these drugs were not part of any concrete intervention and were unlikely to undergo 
any changes by external factors) [90]. The proportion of patients on neuroleptics was in 
addition followed as a time-series (a sequence of data points, measured typically at successive 
times spaced at uniform time intervals) [91-93] in two nursing homes from 23 October 2008 
to 15 July 2010. 
Before-data 
We used data from the prevalence studies described above as “before-data” in the intervention 
study. 
Intervention 
After defining endpoints through the before-survey we installed an electronic, structured 
patient record system which included decision support. The system had been developed and 
operating at Løvåsen educational nursing home (developing institution) for several years, 
funded by the Norwegian Medical Association and the Norwegian Research Council. 
Installation and training were carried out in the last quarter of 2008, and 6 of the 7 nursing 
homes were running the system on a daily basis from January 2009 for 12 months. After the 
active intervention period the number of nursing homes running the system was reduced to 
three institutions, owing to contracts between Bergen Municipality and another vendor having 
been signed before the project started. Løvåsen Nursing Home and two of the study 
institutions continued, and were the only institutions available for follow-up data. Data had to 
be collected directly from the electronic patient record system. 
The technical intervention consisted of population filters and reminders. The system 
incorporated filters and alarms within several areas but we decided to test 4 filters and 2 
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reminders. Population filters were predefined filters that produced lists of patients according 
to criteria in seconds. The tested population filters were: a) “patients taking neuroleptics” (list 
and proportion), b) “patients taking warfarin” (list and proportion), c) “patients with the 
diagnosis atrial fibrillation and their treatment status” (list and proportion) and d) “patients not 
weighed for last 30 days” (list and proportion). Tested reminders visible in each patient’s 
record, if the criteria were met, were: a) “patient has diagnosis of atrial fibrillation but is not 
on warfarin”, b) “patient not weighed for last 30 days”. Figures 1-3 in this summary and 
figures 1 and 2, publication 4 demonstrate how this was arranged within the application. 
Results from the before-study were presented to the participating doctors during the first 12 
months of intervention through three two-hour lectures. 
After-data 
Two institutions (E and F in table 1, publication 2) participated in the after-study. To collect 
the data we used the population filters in the medical record system to find the proportions of 
patients on endpoint drugs, internal controls and patients not weighed for the last 30 days. 
Before-data were extracted from the prevalence study for institutions E and F (N = 183) for 
the before-after analysis. Institution E participated with an additional department (22 patients) 
in the intervention study (N = 205, after). 
To study user satisfaction we performed an anonymous survey among the doctors, nurses, 
assistant nurses and physiotherapists (N = 504). Potential respondents were all users defined 
in the electronic system. They were invited by e-mail to respond to an electronic 
questionnaire. 16 questions about position and several aspects of their view on the 
functionality of the application were presented. Questions were closed, with a score from 1-5 
(worse – better). The survey was constructed by a group of study nurses from the institutions, 
with technical organization by the vendor. 
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Results 
Table 1. Summary of published results 
Main topic Major results 
Primary objectives 
The intervention 
study 
The proportion of patients taking neuroleptics was reduced from 33.0% to 21.5% 
i.e. a difference of 11.5% (95% CI: 2.3 to 20.6%). Warfarin increased from 3.0% to 
9.8% (p = 0.013), i.e. a difference of 6.8% (95% CI: 1.6 to 12.1%). 
The proportion of patients not weighed for the last 30 days was reduced from 72.6% 
to 16.0% (p < 0.001), i.e. a difference of 56.6% (95% (CI: 47.5 to 64.5%). 
The user survey showed high user satisfaction. 
Secondary objectives 
Hospitalizations 
from nursing 
homes 
Of all admissions 61.0% was to medical wards (ex pulmonary ward), 29.4% to 
surgical wards, 4.4% to the pulmonary ward, 3.0% to the neurological ward and 
2.2% to other wards. 
For the medical and surgical wards, infections, fractures, gastrointestinal and 
cardiac diagnoses stood out as the most frequent reasons for admissions. 
The average length of stay was 4.3 days. There was no significant difference 
between the average length of stay on medical and surgical wards. 38.0% of the 
admissions had duration of only one inpatient day. 
Of all the admissions from all nursing homes in Bergen during 12 months (N 
1,311), infection diagnoses represented 25.0%. Pneumonias and suspected 
pneumonias represented 51.0% of infections and 12.8% of all admissions. The 
incidence of hospitalizations caused by infection was 138/1,000 nursing home beds 
per year. 
Fractures were the second most frequent cause counting 10.2% of admissions. Hip 
fractures represented 71.7% of fractures and were the commonest. 
Fracture incidence varied between nursing homes from 0 to 16/100 patient years, 
the average being 6.4. The incidence of fractures treated in hospital among the total 
population was 5.6/100 patient years during the 12 months under review. 
Admissions from nursing homes to the medical wards made up 6.1% of the total 
number of admissions. For surgical wards the admissions counted for 3.8%. 100 
nursing home beds create about 150 bed days in medical wards and 72 in surgical 
wards. 
Linear regression analysis showed a significantly higher admission rate for nursing 
homes with a high proportion of short-term beds than with a low proportion. 
The study on 
psychoactive 
drugs 
 
 
 
 
 
The average number of total number of regular drugs was 6.1 per patient. Classified 
according to principal ATC groups, the three most frequent were drugs for; ”nervous 
system”, ”digestive organs and metabolism” and ”heart and circulation”. 
The average number of as-needed drugs per patient was 3.8. 
24.4% were regularly given one or several neuroleptics, 9.7% of the patients had 
neuroleptics by way of an as-needed prescription. 6.4% of the patients on regular 
neuroleptics were using two different ones regularly. Risperidone was the most 
frequent regular given antipsychotic drug, haloperidol the most frequent as-needed 
neuroleptic. 
14.6% of the patients were on opioids (N02A) by way of regular medication and 
28.7% by way of an as-needed drug. 41.5% of the patients received antidepressants 
as regular medication. 
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Prevalence's of long-term patients in nursing homes being prescribed psychoactive 
medication were as follows: neuroleptics regular 244/1,000 and as-needed 98/1,000, 
antidepressants regular 419/1,000, anxiolytics regular 220/1,000 and as-needed 
415/1,000, opioids regular 146/1,000 and as-needed 287/1,000. 
There were significant differences between nursing homes as a percentage of patients 
on drugs within the actual ATC main group. Differences were highly significant 
statistically for morphine, neuroleptics and antidepressants. 
Some patients being given drugs for Parkinsonism were also on neuroleptics, and 
prevalence of current medication was 2/1,000 among all long-term nursing home 
patients. 
Patients with impaired cognitive function were prescribed significantly fewer regular 
drugs than patients without impairment. The average for patients without impairment 
was 7.1 drugs and for the patients with impaired cognitive functions 5.7 drugs. There 
was no difference in the number of as-needed drugs for the two patient groups. 
In general there was a tendency to lower the prescription rate of all cardiovascular 
drugs for the patients with reduced cognitive functions, significantly for ACEI/A2B 
and diuretics. Neuroleptics were more frequently prescribed to patients with reduced 
cognitive functions. ProBNP (brain natriuretic peptide) was significant higher in the 
patient group without cognitive impairment. No such differences existed for atrial 
fibrillation or renal function. 
With regard to comorbidity we did not find any associations with the use of 
neuroleptics and stroke suffered or associations between neuroleptics and patient 
weight or weight loss/30 days. 
Use of antidepressants was positively associated with patient weight. No associations 
for benzodiazepines or hypnotics were found with stroke, weight or weight loss. 
The atrial 
fibrillation and 
heart failure 
related results 
18.8% of the patients had atrial fibrillation (AF). There was no significant difference 
in the occurrence of AF between the nursing homes. 
14.3% of AF patients were anticoagulated with warfarin. 
Significant differences in treatment for AF with warfarin existed between the nursing 
homes (from 0 to 50%). 
55.8% of patients who had suffered a stroke received some kind of antithrombotic 
treatment (ATC = B01A). 8.3% of these patients were given warfarin. 24.3% of 
patients with both stroke and AF were given warfarin while 73.0% were given 
warfarin or some other antithrombotic treatment.  
Patients with AF receiving no warfarin had suffered stroke significantly more often 
than those without AF . A patient with AF had 2.75 times higher odds of having 
suffered a stroke than patients without AF. 
13.2% of all patients had ProBNP > 225 pmol/l. 
Of cardiovascular related drugs, only diuretics and heart glycosides were used 
significantly more in the group with ProBNP > 225 pmol/l. 
Of the 36 patients with ProBNP > 225 pmol/l and adequate renal function (eGFR > 
50 ml/min.), 8 (22.0%) were given ACE/A2B. 
A multiple linear regression analysis gave the following prediction equation between 
age, weight and renal function: 
                                                  
For example for an 80-year-old patient weighing 70 kg and having eGFR = 30 the 
predicted ProBNP is 129.39 pmol/l.  
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Results from sales statistics analysis 
Previously unpublished data. 
The monetary drug expense is not published due to business secret reasons. Institution 
differences are however illustrated by total DDD per bed per institution in figure 4.  
 
Figure 4. Differences of total drug DDD per bed between nursing homes (N = 35, min 1042, 
max 2821, SD 315,9) in 2011 in Bergen, Norway. Rightmost column shows average total 
DDD. 
 
Several analyses were performed to shed light on the use of drugs per institution and possible 
impact factors. We did not find any correlations between “total DDD per bed” and “total 
number of beds”, “short-term factor” or if the institutions were public or private, as 
demonstrated in figures below. 
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Total DDD/places by total beds 
 
Figure 5. Association between (total yearly orders of drugs per nursing home (DDD))/beds 
and total number of beds among 35 Norwegian institutions ( p = 0.4078). Square marks = 
institutions without short-term beds, round marks = institutions with short-term beds. 
 
Total DDD/places by short-term beds/total beds 
 
Figure 6. Association between(total yearly orders of drugs per nursing home (DDD))/beds 
and short-term bed factor among 35 Norwegian institutions (p = 0.1987). Square marks = 
institutions without short-term beds, round marks = institutions with short-term beds. 
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Total DDD/places by Public (K)/Private (P) 
 
Figure 7. Association between (total yearly orders of drugs per nursing home (DDD))/beds 
for private (P) and public (K) nursing homes in Bergen Norvay. (Wilcoxon, p = 0.1753). 
 
Total DDD/places by short-term beds yes/no 
 
Figure 8. Association between (total yearly orders of drugs per nursing home (DDD))/beds 
for institutions with short-term beds among 35 nursing homes in Bergen, Norway (Wilcoxon, 
p = 0.5525). Square marks = institutions without short-term beds, round marks = institutions 
with short-term beds. 
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Total DDD/places by short-term bed factor, no short-term beds excluded. 
 
Figure 9. Association between (total yearly orders of drugs per nursing home (DDD))/beds 
for institutions with/without short-term beds among 35 nursing homes in Bergen, Norway, 
excluded from analysis institutions without short-term places (p = 0.0027). Square marks = 
institutions without short-term beds, round marks = institutions with short-term beds. 
 
Calculating the impact of increasing number of short-term beds on the different major ATC 
drug subgroups, we did not see any correlation for gastro-drugs, nervous system drugs or 
respiratory system drugs, however a positive correlation existed for cardiovascular drugs (N 
35, R
2 
 = 0.22, p = 0.0042) and antibiotics (N  = 35, R
2
 = 0.14, p = 0.0262). 
We found considerable differences between institutions for all major ATC-groups with regard 
to total yearly DDD per bed as demonstrated in the figures below. 
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Figure 10. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group A, among 35 nursing institutions in Bergen, Norway (max 640.87 min 158.74, mean 
374.02, SD 106.56). X-axis, coded names of institutions. 
 
 
 
Figure 11. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group C, among 35 nursing institutions in Bergen, Norway (max 607.64 min 134.86, mean 
399.61, SD 108,63). 
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Figure 12. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group B, among 35 nursing institutions in Bergen, Norway (max 476.33 min 161.05, mean 
282.81, SD 63.23) 
 
 
 
Figure 13. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group J, among 35 nursing institutions in Bergen, Norway (max 83.62 min 9.19, mean 42.61, 
SD 19.27). 
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Figure 14. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group N, among 35 nursing institutions in Bergen, Norway (max 867.87 min 251.83, mean 
538.75, SD 113.87) 
 
 
 
Figure 15. Differences of (total yearly orders of drugs per nursing home (DDD))/beds, ATC-
group R, among 35 nursing institutions in Bergen, Norway (max 310.56 min 14.54, mean 
141.45, SD 71.78) 
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Figure 17. Demonstrates how “nervous system ATC subgroups” contribute to the total 
nervous system DDD orders per year and bed. The x-axis is log-transformed to increase 
the visual differences and only the trend-lines for each ATC drug group are shown. The 
upper blue line refers to (total yearly N-nervous system DDD orders)/beds per 
institution, sorted according to increasing values. In 35 nursing homes in Bergen, 
Norway. 
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A P 31 29 2 1512,69 339,90 161,05 297,26 18,74 481,33 38,40 2,19 40,67 43,92 136,13 58,91 16,13 134,19
B K 100 80 20 2050,21 530,49 247,86 442,18 83,62 415,59 30,33 14,64 15,89 28,85 137,71 32,08 12,14 169,71
C P 174 154 20 1789,25 373,28 179,16 367,95 33,15 552,73 57,28 22,77 24,41 59,11 159,88 13,39 13,25 122,60
D P 38 38 0 2069,85 441,72 245,84 450,86 22,28 581,70 37,48 24,27 61,41 74,78 221,71 52,65 2,71 193,16
E P 82 82 0 1920,86 370,86 307,27 313,07 39,12 593,09 59,28 15,87 50,78 49,54 168,44 54,33 36,91 117,81
F K 84 63 21 1965,95 455,53 384,69 294,55 46,81 524,27 50,90 49,07 49,85 45,42 154,56 23,84 12,78 154,11
G K 23 23 0 1650,16 231,27 338,62 412,86 13,52 462,32 11,99 43,60 6,88 96,57 167,39 56,99 0,00 60,72
H K 60 60 0 1935,70 437,22 283,05 345,76 50,38 608,45 73,11 19,05 45,39 105,58 197,22 9,27 14,92 95,14
I K 90 90 0 1980,71 402,61 315,48 404,66 49,95 552,59 53,16 38,44 32,44 10,04 194,81 42,59 11,99 140,35
J K 20 20 0 2139,18 338,53 271,42 134,86 32,41 867,87 57,93 28,91 72,00 160,40 259,48 9,80 22,20 181,84
K K 34 34 0 1568,37 295,55 295,33 239,38 16,74 462,53 5,54 28,13 45,93 29,45 216,53 46,19 8,09 90,44
L K 60 35 25 1850,72 282,15 313,84 473,38 53,80 469,28 68,69 25,60 15,61 70,73 128,50 38,13 20,60 75,91
M P 20 20 0 2343,36 469,05 476,33 423,63 63,51 535,53 24,05 20,68 38,17 97,67 180,20 0,00 15,75 157,82
N K 107 79 28 2059,21 435,53 398,89 488,24 29,35 481,10 27,80 19,44 16,95 62,88 109,98 43,53 7,94 67,10
O P 54 54 0 2141,81 355,63 250,95 539,04 37,96 586,22 46,56 80,15 55,85 100,37 179,59 19,65 18,26 148,52
P K 60 52 8 1727,21 307,45 223,15 344,51 51,62 625,43 55,96 24,69 56,66 24,19 285,62 42,49 13,23 87,52
Q K 183 129 54 2163,38 359,30 382,62 448,91 51,94 656,76 39,95 40,90 41,39 45,42 223,05 31,11 60,11 123,64
R P 29 26 3 1702,92 298,67 237,01 513,25 35,49 410,99 17,64 6,74 9,31 83,85 124,22 67,91 0,00 39,83
S K 131 101 30 2046,40 489,21 251,27 342,50 46,85 553,53 46,41 19,35 20,43 22,85 198,88 31,61 26,37 174,85
T K 72 56 16 2170,03 366,12 230,34 474,12 28,89 655,02 35,31 107,98 27,95 60,42 125,83 42,81 52,75 261,84
U K 30 30 0 2121,77 312,23 301,57 405,56 73,98 489,45 31,05 6,82 24,75 24,33 193,80 18,23 49,97 210,29
V K 64 47 17 1719,74 245,02 288,09 405,16 59,93 460,86 43,26 25,35 28,84 74,97 162,37 4,78 25,59 75,24
W P 36 36 0 1883,75 379,58 292,38 426,71 33,75 475,80 45,18 14,02 20,94 38,94 179,59 33,95 16,89 113,16
X K 30 30 0 2186,28 530,57 320,57 351,13 34,85 482,83 42,60 14,86 28,00 48,00 145,21 78,09 27,03 310,56
Y P 34 34 0 1581,93 265,00 278,10 340,27 39,70 431,53 52,35 58,85 21,26 51,97 89,78 36,12 0,00 113,09
Z P 27 27 0 2821,08 640,87 278,72 601,96 61,58 772,96 89,49 12,87 34,01 76,91 334,07 20,34 13,56 301,36
ZA K 25 22 3 1674,64 248,42 258,46 433,59 18,03 448,33 12,58 86,36 35,28 5,60 152,47 30,30 10,72 82,81
ZB P 24 24 0 1042,35 195,34 233,39 247,47 11,39 251,83 7,21 19,08 17,88 19,78 86,45 26,28 20,39 14,54
ZC P 46 44 2 1489,42 158,74 253,42 343,57 9,19 472,37 13,85 53,59 18,70 87,21 149,26 57,90 49,13 131,20
ZD K 53 30 23 2288,53 369,98 284,86 607,64 67,98 492,88 60,89 12,01 17,17 87,10 103,04 18,91 4,21 250,95
ZE K 65 51 14 2108,55 365,63 292,97 508,95 71,31 541,36 70,16 13,57 48,24 79,22 143,30 35,57 9,85 156,86
ZF K 64 5 59 2304,22 432,15 318,79 579,34 64,69 494,69 52,40 16,09 21,86 86,84 116,10 30,25 7,81 223,35
ZG K 64 64 0 2108,61 441,14 291,78 436,38 52,22 580,20 26,99 134,38 22,55 11,96 166,20 28,45 13,42 118,42
ZH K 74 74 0 2058,80 350,24 225,11 350,69 57,21 677,54 67,24 54,96 37,25 35,39 214,12 17,14 56,81 209,14
ZI K 60 60 0 1931,75 575,70 185,78 196,93 29,42 707,10 41,44 48,67 82,56 71,46 191,60 26,83 23,75 42,55
Table 2. Total yearly drug orders as DDD's per bed for selected ATC-groups of drugs among 
35 nursing homes in Bergen, Norway, 2011. 
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Weight related results 
A total of 488/513 of the patients (95.1%) were weighed, the average weight being calculated 
as 62.03 kg (SD = 14.38, min. 30.1, max. 118.7). The previous weight of 431/513 (82.7%) of 
the patients was found in patient records, the average weight being 62.9 kg (SD = 14.65, min. 
= 30, max. = 124). Women had an average weight of 58.8 kg and men 69.1 kg. 
On average 125.1 days (N = 416) had passed between control weigh-ins. 
Significant differences were found between nursing homes regarding proportion patients 
weighed last 30 days (Pearson, p < 0.0001), corrected for “length of stay”. 
In the two institutions participating in the before-after intervention study 72.6% of patients 
had not been weighed last 30 days. The average for all institutions was 52%. 
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Discussion - primary objectives 
The role of nursing homes in the delivery of social and health care services differs between, as 
well as within, countries [94]. Nursing homes in many countries are managed as part of social 
care. These differences may influence the health issue landscape and composition of staff. 
Thus comparisons and generalizations based on our findings should be done with care.  
Discussion of the intervention study 
Publication 4. 
Due to an unforeseen decision by the county administration, which made a few months 
extension of the study impossible, the material turned smaller and weaker than planned. We 
are well aware of this fact, but decided to publish the results despite this, since we were able 
to test the hypothesis by different methods. Firm scientific proof is however not presented by 
this study. 
Endpoints changed significantly during intervention by increased use of warfarin, decreased 
use of neuroleptics and a higher weighing rate. Job satisfaction was not adversely affected. 
The methods for evaluating change and improvement strategies are not well described. Such 
study designs should generally be used in a context where they build on appropriate 
theoretical, qualitative and modeling work, particularly in the development of appropriate 
interventions [95]. We feel we have properly documented the fields in need of improvement 
and thus study objectives. 
Baseline and follow-up data for the first cross-sectional sample were collected, by the 
prevalence study (before) and (in the case of the second sample) after the intervention, 
respectively. As it was not possible to collect follow-up data for everyone included in the first 
study (for political reasons), and the patients included in the second sample were not identical 
to those in the first due to deaths, the two samples were compared using methods for 
comparing unpaired data. This is a weakness, but to compensate for the 40% or so annual 
death rate in nursing homes, the sample size would have had to be much higher to be able to 
use patients as their own controls, and this may not have been advisable when testing front-
end technology in the first study. 
Our design must be seen in light of the immaturity of research in nursing homes in general. 
As far as we know, neither recent data exist on the prevalence of atrial fibrillation in a nursing 
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home population and the use of warfarin, nor is information available on how well basic 
procedures like weighing are conducted. More information has been available on the use of 
neuroleptics. There was therefore a need to do a prevalence study, define valid endpoints and 
to do an intervention study. It may be claimed that we should have separated the tasks, but 
nursing homes are in great need of improvement strategies and time is short before the elderly 
wave is set to impact heavily on nursing home demands. Financial and political limitations 
played a role too, obstructing any possibility of performing a full-scale follow-up study. But 
conversely, it would have been a challenge, in a randomized trial within one municipality, 
albeit with 37 institutions to choose from, to avoid study group pollution and the “Hawthorne 
effect” [95, 96]. Starting out with a comprehensive and expensive randomized study would 
probably not have been ethical due to all the uncertainty and possible threats from new 
information technology systems, and hence probably difficult to fund. When we started, we 
did not know if it was possible to install the application, educate and prepare for critical daily 
use in 7 institutions with 500 to 800 users within a timeframe of 4 months. Looking back, this 
may be regarded as the most convincing result of the project. 
We used a design where we evaluated endpoints in a before-after study with internal controls 
[91-93]. The stability of internal controls throughout the intervention reinforces the internal 
validity of the study.  
With the technology presented, effects can be measured continuously. However, we cannot 
conclude the extent to which the technical aspect or “awareness of the performance process” 
is responsible, through education, for the changes measured. Yet without any performance 
figures it is not possible to focus on changing processes, so the two ways of influencing 
results are not independent factors.  
The technology made it possible to monitor performance without time-consuming traditional 
studies and made performance feedback possible. This is a relatively new concept in medical 
research, made possible by structured medical input applicable to automatic and continuous 
analysis. Consequently, the proportion of patients taking neuroleptics could also be followed 
using time-series, giving more detailed information about the changing process and 
strengthening the validity of the effect results. As a critical information element, drugs were 
punched into each patient record at an early stage of the implementation process and this gave 
us a sufficient “before-point” on the time-series. We discovered that the significant change in 
  Page 46 
 
  
the before-after study was due to only one of the participating institutions, and that this 
institution showed up a clear brake in the curve at the point of intervention start-up.  
Concerns about structuring medical templates do exist. Some claim that the templates do not 
simply document the task but change the nature of the work and lead to ‘institution-centered’ 
care over patient-centered care [97]. In our view it is not possible to structure all information 
in electronic medical records. All structured forms therefore should have unlimited free-text 
option. Structuring information should have a clear predefined purpose defined as an alarm, a 
statistic or a definition of a population. Templates may also be structured in the sense of 
structured "questions" but free-text "answers" and may this way serve as important reminder 
notes. This reduces information gaps due to employee knowledge differences. We however 
support the view that more research is needed. 
Some authors claim that decision support applications may introduce unexpected errors, 
mainly in the process of entering and retrieving information, and in the communication and 
coordination process that the Patient Care Information Systems (PCIS) is supposed to support 
[98-100]."- Factors that could diminish information and communication technology (ICT) 
harm, include adoption of common standards, technology maturity, better system 
development, testing, implementation and end user training. Factors that will increase harm 
rates include complexity and heterogeneity of systems and their interfaces, rapid 
implementation and poor training of users" [101]. 
It is of course important to be aware of these circumstances as even increased mortality has 
been proven after introducing new technology [102]. Keeping updated on new knowledge is 
important when constructing new systems and studies to minimize unexpected consequences. 
It would however be in opposition to common logic to make these cautions prevent 
introducing carefully designed electronic systems. 
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Discussion - secondary objectives 
Discussion of the hospitalization study 
Publication 1. 
We estimated that close to 100% of the admissions from nursing homes (A) take place using 
the ambulance service and therefore consider the basic material reliable. However, it contains 
no information about the degree of general debilitation or the degree of dementia. This is a 
weakness. It is difficult to decide whether or not the admissions were unnecessary. The 
material is too superficial for that. An indication of co-morbidity is given by numbers of 
secondary diagnosis, which range from 0 to 9, averaging 2.9. Our project only had access to 
anonymous data and could not count re-admissions, therefore. This strengthens the material in 
a patient and data security perspective, but calls for further research. It has previously been 
shown that infections are the most common causes of hospital admissions from nursing homes 
[103-105]. This is confirmed by our results [103, 106-110]. 
Some may claim that the number of observations is low with regard to the regression analysis 
(32/15 institutions). We are however inclined to think that institutions are less volatile then 
individuals, especially as all of them in this study are within the same county and are 
administered by the same management and thus are similar with regard to nursing factor, 
reimbursement, level of education etc. The included institutions cover 91% of all nursing 
homes within the county which secures validity within this population. 
As clearly shown in the publication, two of the nursing homes are outliers by their extra high 
short-term factor and doctor employment factor. Both factors seem to be correlated to 
increased number of hospitalizations. We therefore performed a multiple regression analysis 
of all admissions in 2007, both with and without the outliers included, containing both doctor 
employment factor (t), short/long-ratio (r) and a factor if the institution had short-term beds at 
all (k); 
A = b0 + b1t+ b2k + b3kr, i.e. 
if k = 0 (no short-term beds): A = b0 + b1t, and 
if k = 1 (with short-term beds): A = b0 + b1t + b2 + b3r. 
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A = 25.047 -0.690t+ 21.676k + 6.730kr, which means that there is no effect of doctor 
employment factor (t) corrected for short-term/long-term factor (p = 0.942). If k = 0 (no short-
term beds): A = 25.047-0.690t, if k = 1 (with short-term beds):  A = 25.047-0.690t + 21.676+ 
6.730r. The analysis was repeated with two nursing homes with extremely high doctor 
employment factor excluded (p = 0.280). 
In other words: Nursing homes with short-term beds have more hospitalizations and the 
number increases with increasing short-/long-term ratio even when adjusted for varying 
doctor employment factor. Also when including the interaction between k and t in the 
analysis, the result is very similar, and we thus have no reason to believe that doctor 
employment factor has different impact on hospital admissions from nursing homes with and 
without short-term beds. 
The results above refer to the analysis with all 32 institutions included. Excluding the two 
outliers from the analysis leaves no significant results at all. It is no clear-cut answer to the 
question if the two outliers should be included in the analysis or not. They are atypical due to 
high employment factor, on the other hand it is the effect of the employment factor we intend 
to examine and the other institutions do not vary enough in their employment factor to 
evaluate the effect if excluding the two highest values. It is a well known principle by the 
regression analysis that spread values along the x-axis strengthens the analysis. We do not see 
other differences between the two outliers and the other nursing homes which should 
considerably impact the result.  
We also performed residual analysis for the regression analysis to check if there are reasons to 
assume differences from expected normal distribution. We did not find deviations which 
should impact the referred results. 
So we conclude that increasing short-term bed factor increases hospital admissions and that 
increasing doctor employment factor does not reduce hospitalizations significantly. The 
results are consistent even analyzing subgroups of nursing homes, for example big/small. 
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Discussion of the clinical prevalence studies 
Publications 2 and 3. 
For most planned purposes we consider our material valid and robust with regard to both 
sample size and tested parameters. However, the size of the material may be too small to 
calculate the prevalence of rarer diagnoses/drugs. A weakness of our study is that 
comparisons between diagnosis and drug treatment cannot be performed. The simple test we 
used to decide whether or not patients had reduced cognitive functions can be questioned [88]. 
Using Minimal Mental Score was beyond project resources. Our method was to a certain 
degree validated, however, by comparing the extent to which dementia drugs were given to 
patients scoring above 0 (reduced cognitive functions), giving a 95% overlap, and to a certain 
degree by medical record data. We thus found our method sufficient for the purposes of the 
study.  
We found good concordance with results from previous studies in terms of the drug groups 
most frequently prescribed (N, A, C, B, R) [111]. The decreasing use of neuroleptics in 
nursing homes discussed by other authors has not been verified [48]. 
In our study we have demonstrated sizable differences between the nursing homes when it 
comes to the use of medications, which cannot be explained by different prevalence alone. 
Calculating the total use of drugs within each drug class using DDDs, increased the 
differences between institutions. This probably shows that institutions with a high percentage 
use even are using higher dosages. To examine treatment differences between nursing homes 
even further we analyzed the yearly sales statistics. The sales statistic file from vendor gives 
total and comprehensive information on drug orders from all nursing homes in Bergen. The 
total yearly figures are based on multiple orders (i.e. weekly) for each institution and there is 
thus reason to believe that the figures give reasonably representation of total drug use. The 
results confirm the results from the article on psychoactive drugs in seven nursing homes. 
There are considerable differences in drug use between institutions, which, as far as we 
consider, cannot be explained by prevalence differences. 
We found that 18.8% (91) of the patients had AF in our study population. The prevalence of 
AF has been found to be 17% for patients over 65 years and to increase with age [112]. Our 
prevalence is comparable to earlier findings and age groups. Patients with AF older than 65 
have been consistently undertreated with anticoagulants [113]. This is consistent with our 
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finding that the warfarin treatment rate was low (14.3%). Even a warfarin treatment rate of 
about 65% of elderly AF-patients is considered problematic by several authors [73, 114]. In 
our study, we found a significant increase in stroke prevalence in AF patients not treated with 
warfarin, which illustrates under-treatment. Reasons for low treatment rates might be fear of 
intracranial haemorrhage and falls [114] but with systematic monitoring the risks associated 
with oral anticoagulation treatment appears to be low [115]. To start life-prolonging 
treatments may not always be as obvious to do in nursing home patients compared to younger 
patient groups. Suffering involved with stroke is considerable however, and should be 
prevented if possible, at all ages. 
Based on our estimates the stroke risk among nursing home residents with AF was 8.5 – 
18.2%, considerably above 5.6% which is considered the highest bleeding risk score 
according to Shireman et al. [73]. Increased risk of bleeding episodes on warfarin treatment 
usually occurs among the elders aged within two months of start-up [116]. On the other hand, 
increased CHADS2 score (4-6) in the oldest (>85) population may increase bleeding risk 
[117]. Treatment must always be individualized therefore. 
McCormick et al. [118] found that AF was present in 429 (17%) of 2,587 long-term care 
residents. Overall, 42% of these AF patients were receiving warfarin. This is consistent with 
our study when it comes to AF prevalence and more in line with our own opinion of a 
reasonable treatment level of frail nursing home patients than our own findings. 
It may be claimed that using ProBNP as the only parameter to diagnose insufficiently or non- 
treated heart failure weakens the study and most procedures in force recommend 
echocardiogram to diagnose heart failure. On the other hand, an echocardiogram is often 
impractical as a diagnostic tool for nursing home patients both due to equipment price and 
physician qualifications. Transporting patients to a specialist cannot always be recommended 
for these frail patients either. 
The cut-off value of ProBNP as a diagnostic tool for heart-failure in need of treatment, in 
different populations, is a matter of discussion. The high median age in our cohort made us go 
for a relatively high cut-off value (as increasing age leads to increasing ProBNP levels) even 
though that weakened sensitivity of the test. The main purpose of our study was however to 
examine if under-treatment existed in heart failure patients. Therefore, specificity (the 
proportion of negatives in the test which are correctly identified) was more important than 
sensitivity (proportion of actual positives which are correctly identified). – We needed to be 
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fairly sure to exclude healthy patients, missing some sick patients however, strengthens the 
under-treatment conclusion. 
The identified risk by elevated ProBNP, whether it's a risk for death or a risk for heart failure 
hospitalization, lower values are better, higher values are worse. What one also knows, based 
on the data from Val-HeFT, is that while a single measurement is useful, serial measurements 
seem to inform even better prognostic value. This also refers to patients above 75 [119-121].  
Cut-off limits of ProBNP as a diagnostic and prognostic tool in heart failure are discussed in 
numerous studies. In one study (mean age 73 years, followed for 6 years and registering all 
cardiovascular mortality) persons with ProBNP above 200 pmol/l had higher mortality [122]. 
In another study, 24 out of 25 patients were classified correctly with regard to heart failure, as 
compared with cardiac echo, using a ProBNP cut-off of 223 pmol/l [123]. 
Our results of bivariate fits of ProBNP by eGFR, weight and age (which are the known 
biasing factors), lead us to the conclusion that nursing home patients with a ProBNP > 225 
pmol/l were more likely to have heart failure and, above this level, the high ProBNP values 
were not caused by high age, low weight or renal failure. 
We found 13.2% (59) had a higher ProBNP (> 225 pmol/l). 8 - 10% was the prevalence rate 
for heart failure in earlier studies [124].  Only ten (16.7%) of the patients were given both 
ACE/A2B and diuretics, which suggests under-treatment. This impression is reinforced by the 
lack of significant ACE/A2B differences in treatment rates between the patient group with 
high ProBNP and normal renal function (eGFR > 60 ml/min  – giving a therapeutic indication 
without renal contraindication) compared to the rest of the cohort. 
A high proportion of renal failure among the elderly has been considered to engender 
reservations in prescribing ACE inhibitors for this patient group [125]. However, it is not 
appropriate to withhold ACE inhibitors for heart failure in patients with only mild renal 
failure [126, 127]. Our findings show a low treatment rate in patients with adequate renal 
function as well. 
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“Healthcare administration through structured records” (HATS) 
Based on our total work our belief in structured medical records, as a way to audit and 
improve medical quality, has increased. We think there are reasons to examine this further in 
future projects. This may prove advantageous for healthcare as such, as this kind of electronic 
infrastructure can add clinical variables to the management of health institutions by means of 
"New Public Management" [128-133]. 
New Public Management (NPM) 
The start of the New Public Management (NPM) as the wave of reform for the public sector 
has its origins in Australia (1983) and New Zealand (1984). Behind the NPM is the criticism 
of an inefficient public sector. “NPM has thus been a reform wave with a core idea, but with 
varying and inconsistent implementation in different countries. It has had strong coalitions 
behind in many countries, coalitions that are now beginning to fade. It has been characterized 
by a one-dimensional and economically-oriented thinking, and led to efficiency gains, but 
also weakened the political control and increased bureaucracy. It has now been supplemented 
and modified by post-NPM reforms in many countries, characterized by less emphasis on 
efficiency thinking and more emphasis on the management and coordination” [134]. 
NPM criticism 
The more specific criticism against NPM, as it is reflected in various government scientific 
studies, is that the NPM is far too one-dimensional efficiency-oriented. "Efficiency is 
important, but must be balanced against other important and legitimate concerns in the public" 
[135]. "A main point is that this type of thinking is underdeveloped when it comes to insight 
into the structural design in the public and that the reform elements that come from the 
different types of theory is partly poorly justified and partially encounter against the other, so 
that the result is complex and hybrid structural solutions” [134]. One of the early writers of 
NPM identified several ways in which public organizations differ from the private sector
1
. He 
also identifies that the reform tends to ignore these differences [136]. 
                                                 
1 
  degree of market exposure—reliance on appropriations 
 legal, formal constraints—courts, legislature, hierarchy 
 subject to political influences 
 coerciveness—many state activities unavoidable, monopolistic 
 breadth of impact 
 subject to public scrutiny 
 complexity of objectives, evaluation and decision criteria 
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The most obvious sign of NPM in the Norwegian health care system is probably the activity 
based financing in both first- and second line services and especially the DRG-system 
(Diagnosis-related group) in the hospitals. Market models were difficult to apply without the 
goods and commodity prices. It was therefore constructed an artificial list of priced 
“products”. The DRG-system has been continuously changed and refined the last 30 years to 
try to make it comprehensive and correct despite the difficulties to estimate cost of production 
of the “products” due to the tremendous complexity of the task. The critics of NPM in 
Norway are moderate, but exist, especially from the left sided politicians. The criticism is 
directed mainly against the market thinking as such and not more analytical, - towards the 
system-design. 
"Unit Price-funding has already led to increased class differences between patients. It has 
therefore been a shift towards the profitable patients at the expense of the unprofitable. Health 
workers react already today strongly against the health care system becomes more money-
oriented, as we have also seen it in other countries with similar model. Unit price system leads 
to an increased need for management" [137]. Some are not gracious in their criticism; "The 
results are inefficiency, poor service, red tape and frustrated employees" [138]. 
Norwegian health authorities however perform a sober view of the DRG system and the 
activity-based portion of the financing (financing consists of a framework financing part and 
an activity-based part) indicated by a declining activity-based proportion the later years (now 
about 25%) and plans to maintain this level [139]. 
Medical diagnosis is no clear-cut procedure, and it is likely that DRG coding affects the 
diagnosis. DRG coding changes the system to describe. A diagnosis is not the result of 
standardized practical patterns. Review of patient records shows that there is relatively poor 
correlation between what is documented in the records and how this is expressed through 
codes. Thus, the system will never be so robust that it generates activity statistics as detailed 
and valid as expected by the authorities [140]. The constant changes in the activity-based 
financing and DRG code setting is perceived problematic by the doctors. - The coding is time 
                                                                                                                                                        
 authority relations and the role of managers 
 organisational performance 
 incentives and incentive structures 
 personal characteristics of employees 
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consuming and it feels bureaucratic, especially as extra employees are appointed in order to 
check whether the codes are correct [141]. 
New trends 
Some authors claim NPM has peaked and is now in decline. Critics like Dunleavy now 
proclaim that “NPM is 'dead' and argue that the cutting edge of change has moved on to 
digital era governance (DEG), focusing on reintegrating concerns into government control, 
holistic (or joined-up) government and digitalization”. “The character of the post-NPM 
regime is currently being formed. A range of connected and information technology–centred 
changes will be critical for the current and next wave of change. The overall movement 
incorporating these new shifts is toward ‘‘digital-era governance’’ (DEG), which involves 
reintegrating functions into the governmental sphere, adopting holistic and needs-oriented 
structures, and progressing digitalization of administrative processes. DEG offers a perhaps 
unique opportunity to create self-sustaining change, in a broad range of closely connected 
technological, organizational, cultural, and social effects” [142]. 
Dunleavy defines characteristics of NPM within three main categories
2
. He consider 
interestingly only a few of these factors still to be in force in NPM-countries, namely the 
factors regarding ”improved performance measurement”, ”league tables of agency 
performance”, ”user control”, ”unified rate of return and discounting”, ”development of 
charging technologies”, ”valuing public sector equity” and ”mandatory efficiency dividends”. 
 
                                                 
2
  
1. Disaggregation 
Purchaser-provider separation; Agencification; Decoupling policy systems; Growth of quasi-government agencies; 
Separation out of micro-local agencies; Chunking up privatized industries; Corporatization and strong single organization 
management; De-professionalization; Competition by comparison; Improved performance measurement;  League tables of 
agency performance; 
2. Competition 
Quasi-markets; Voucher schemes; Outsourcing; Compulsory market testing; Intragovernment contracting; Public/private 
sectoral polarization; Product market liberalization; Deregulation; Consumer-tagged financing; User control. 
3. Incentivization 
Respecifying property rights; Light touch regulation; Capital market involvement in projects; Privatizing asset ownership; 
Anti-rent-seeking measures; De-privileging professions; Performance-related pay; PFI (private finance initiative); Public-
private partnerships; Unified rate of return and discounting; Development of charging technologies; Valuing public sector 
equity; Mandatory efficiency dividends. 
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Motivation and productivity 
Fauli discussed in 2010, in an article in the Journal of the Norwegian Medical Association, 
interesting aspects of the health workers' motivation and linked this to the design of reward 
systems. "The Swiss welfare economist Bruno Frey believes that human beings have an 
intrinsic motivation."Crowding-out" theory means that the use of incentives that affect the 
individual's external motivation can reduce their intrinsic motivation. External motivation 
represents the incentives coming from outside, the recognition, reward or punishment. 
According to this theory is monitoring considered a signal of lack of trust, and can reduce the 
intrinsic motivation. With regard to reimbursement systems, Fauli is inclined to think that the 
goal must be to find a form that provides the best quality of care within budget, with minimal 
adverse effects. She therefore suggests a neutral reimbursement system and rather improving 
the quality of treatment by measures that strengthen the quality of doctor's work. Examples 
are voluntary participation in quality registries, with regular feedback of your own activity 
compared to colleagues 'activity' [143]. 
In a management theoretical perspective, this may be seen somewhat different. While the 
medical logic is rooted in duty ethics, where the interests of the individual are in focus, the 
financial/administrative logic is based on the "new ethics" or utilitarianism, where efforts are 
evaluated in a cost benefit perspective. The question is whether the introduction of NPM-
inspired reform measures can lead to value conflicts for doctors and nurses, where they have 
to take into account both what is best for the individual and what will be the benefits to 
society. Doctors and nurses "both serve as good Samaritan to the individual patient and as a 
judge towards the community's needs" [144]. 
Does this have any relevance to the assessments of what is wrong with NPM in its original 
form? The basic idea of NPM seems to be judged as reasonable, but that the gap between real 
markets and the healthcare "pseudo market" is too big. The genuine medical production 
elements do not fit properly the parameters needed to apply market theory. It all turned 
unfavourable due to shortcomings in productivity- and incentive parameters. Instead of 
auditing "the percentage of procedures without complications" one measured "number of 
procedures", and thus introduced an incentive system not matching the wished goals and 
leading to unmotivated employees. 
When it comes to Norwegian nursing homes the situation is partly different from the hospitals 
as the DRG-system is not used in the governance of nursing homes in the municipalities, and 
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depending on which political party is in power, it vary to which extent performance-based 
financing has been implemented [145]. On the other hand, the production of patient focused 
quality parameters is absent and the medical record systems are not constructed in a way 
which makes such production possible [146]. The possibility of rational self auditing, as 
mentioned by Fauli as a quality improving method, is therefore not possible.  
When it comes to production of quality indicators (QI) it is preferable that the data retrieved 
for QIs are obtained by data that already exist, and that data collection for QIs does not mean 
extra workload for health personnel [147]. Easily retrieved data from the patients’ records is 
an example of such data for quality indicators (QI) [148]. Tools to ease the use of QIs in 
clinical settings need to be developed [149]. The Norwegian national system for care statistics 
(IPLOS) does not comply with these demands [150]. 
We are inclined to think thus, that the major NPM weaknesses, which seems to be production 
of user-centred and valid performance statistics and quality indicators, relates both to 
Norwegian first- and second line health services. 
The missing NPM link? 
The question arises then, with reference to the factors discussed above, if it is possible to feed 
the remaining foundations of NPM with digitally-based management tools (DEG) in the form 
of user centred (to meet Bruno Frey) quality parameters that motivates health workers and 
thereby fosters quality improvements and increased productivity? The goal might be to 
"develop a system that makes it possible, through the year, to have full control of what is 
performed and what resources are used" [151]. Our own work and thinking tries to evaluate if 
there is reasons to believe that implementing structured medical recording may be a way to 
reach these goals. And decision support is closely correlated with structured record 
information, because the decision support tools have to respond to information in the record. 
This is easier to accomplish if the underlying data are structured [26]. 
So, if the medical, electronic health record systems are containing structured medical and 
administrative parameters, which have a patient-centred origin, it is possible to design quality 
parameters, which may motivate health workers, and to monitor these continuously. 
It is important to underline the difference between the system which can produce and audit 
quality parameters and, on the other hand, the process of finally decide which quality 
parameters to implement on a broader scale, which is not always a straight forward process as 
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the measure for good result or success has to be agreed upon, and evidenced-based processes 
and structures that underlie the result must be documented. Measurable indicators derived 
from this procedure must be tested in a scientific manner for relevance to nursing home care 
quality and patient-centeredness, reliability in the way it is obtained, comparability between 
facilities, ability of clear interpretation and whether the indicator can be influenced by 
improving quality [149]. In this regard clinical medicine is probably easier to assess than 
nursing, as parameters for scientifically tested "good clinical practice" is already available 
(i.e. "patients with eGFR < 50 ml/min shall not be treated with methformin due to danger of 
worsening renal failure". No doctors would argue against this medical knowledge). 
The table 3 below shows the subpopulations and alarms defined in the test-system. Some of 
these may be used as quality indicators after proper evaluation. At the department and 
institution level the figures 18 and 19 below demonstrates examples of reports which give 
concrete feed-back to the users about performance and statistics. 
Although self-monitoring probably is most effective in quality improvement efforts, few will 
argue that management and authorities should waive their rights of monitoring selected 
quality- and productivity parameters. In structured electronic medical records, based on basic 
datasets, this may be done continuously and electronically, as shown below where the 
percentages of patients using different groups of drugs are compared between institutions 
[152]. Figure 20. 
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Subpopulations defined in UNO GBD Alerts* 
Medical alerts  
Not weighed the last month X 
Pathologic MUST score (nutrition status) X 
Weight loss above 5% last 6 months X 
Patients taking antihypertensive drugs and the last BP is below 120 systolic  X 
Patients with dementia using drugs with anticholinergic effect  X 
Patients using ACEI or A2B and having an eGFR < 60 ml/min  X 
Patients with proBNP > 225 pmol/ l X 
All patients with proBNP> 225 not using ACEI or A2B X 
Patients with drug interactions within the RED risk level (DRUID)  X 
Patients with drug interactions within red and yellow risk level (DRUID) X 
Patients on medications used for Parkinson's disease using neuroleptics X 
Patients on both NSAIDs and warfarin X 
Administrative alerts  
Patient not taken Berger dementia scores last 6 months X 
Patient  not measured BP last 60 days X 
Patient not taken the ECG last 6 months X 
Patient  not taken Hultén nursing load score last 3 months X 
Patient without medical notesby doctor last 90 days X 
Patient not performed MMS last year X 
Patient not checked with blood tests last 6 months. X 
Lists and sub-populations  
Patients with atrial fibrillation and type of blood thinning treatment   
Patients on metformin and their eGFR values   
List of patients with status "monitored"  
List of all patients and the date of MMS  
List of all patients and the date of Berger dementia scores  
List of all patients and the date of labtesting  
List of all patients and the date of/and their nursing load score   
Patients with active enforcement decisions  
List of all patients who have active alerts  and the type of alerts   
All MY patients with event/note last day, 7 days, 30 days, 365 days  
Drug sub-populations  
Patients on: ACEI or A2B  
Patients on: Other antidiabetic agents than insulin   
Patients on: Antibiotics  
Patients on: Antidepressants  
Patients on: Antidiabetics  
Patients on: Antiepileptics   
Patients on: Anti-Parkinson drugs  
Patients on: anxiolytic   
Patients on: Benzodiazep ines  
Patients on: Beta-blockers  
Patients on: Dementia Medicat ions  
Patients on: Dig italis   
Patients on: Diuret ics  
Patients on: DPP-4 inhibitors  
Patients on: Hypnotic  
Patients on: Insulin  
Patients on: Calcium channel b lockers   
Patients on: Warfarin   
Patients on: Neuroleptics   
Patients on: NSAIDs  
Patients on: Opioids  
Patients on: Paracetamol  
Patients on: Thyroid hormone substitusjon  
*An alert pops up within the patients record on due date  
 
Table 3. The table demonstrates filters and alarms defined in the medical 
record system which has been tested. The system was tested for ability to 
impact clinical variables in 7 nursing homes in Bergen, Norway. 
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Figure 18. Demonstrates a report which shows how each department complies with a 
set of routines (e.g. monthly weighing). Missing accomplishments are shown with 
yellow background. 
Figure 19. Demonstrates a monthly report of all injuries recorded. 
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Figure 20. The screen-shot above shows timeline-curves which are comparing the use of 4 different 
drug groups at 3 institutions (percentage patients on drug) in Bergen, Norway. 
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Research update 
An important study with relevance to our work has been performed at Sankt Olav´s Hospital 
in Trondheim and Ullevål Hospital in Oslo, Norway, during the last year. The authors 
“performed an observational study of consecutive unplanned inpatient admissions using a 
structured form to register a set of predefined parameters and free-text notes, including a post-
examination interview with the examining emergency department doctors and nurses. They 
observed 177 patient admissions, excluding any patients under 18 years of age and planned 
admissions. Out of those admitted 68% were living at home with an additional 16% living at 
home, but enrolled in community home care services. 5% were transferred from institutional 
community care and 6% were transferred from other hospitals or specialist outpatient clinics” 
[153]. 5 percent hospital admissions from nursing homes confirm the findings in our study. 
This is important as it confirms that our nursing home materials in Bergen are similar to other 
nursing home populations in Norway and thus strengthens the validity of our findings. 
Another work on hospitalizations from nursing homes in Bergen has been published the last 
year. The acute hospitalizations of the nursing home residents were identified through 
ambulance records (same method as we had used, but a year later). These were linked to 
hospital patient records for inclusion of demographics, diagnosis at discharge, length of stay 
and mortality. Incidence of hospitalization was calculated based on patient-time at risk. 
“The annual hospital admission incidence was 0.62 admissions per person-year among the 
nursing home residents and 0.26 among the community dwellers. In the nursing home 
population the dominant diagnoses were respiratory diseases, falls-related and circulatory 
diseases, accounting for 55% of the cases”. The median length of stay was 3 days 
(interquartile range = 4). The in-hospital mortality rate was 16% and 30 day mortality after 
discharge 30%. Acute hospital admission rate among nursing home residents was high in this 
Scandinavian setting. The pattern of diagnoses causing the admissions appears to be 
consistent with previous research. The in-hospital and 30 day mortality rates are high 
compared to international studies [154]. Also this study confirms our findings a few years 
earlier, especially with regard to diagnostic reasons for hospitalizations from nursing homes. 
We assume this may be similar in Norway as such, even though we must bear in mind that the 
figures apply to populations with university hospitals as primary hospital. 
Performing a PUBMED search on the phrase “electronic decision support” (publication title) 
gives 22 publications from 2012 [155-176]. They all proved more or less positive results. 
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A few studies have been performed since 2005 on drug use among elderly and nursing home 
patients. Methods for reducing drug related problems have been subject to a meta-analysis, 
but results are non-decisive [177]. SSRIs have been withdrawn from nursing home residents 
in Sweden, often successfully [178]. On the other hand psychiatric and behavioral symptoms 
are frequent in nursing homes and the rate increases with the progression of the dementia, so 
systematic programs are needed for disseminating skills and providing guidance regarding the 
evaluation and treatment of these symptoms in nursing homes [179]. 
A recent study confirmed the prevalence findings from our own study. They examined trends 
in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009, in order to 
gain insight in practice development. Prevalence of all psychotropic drugs combined 
increased from 57.6% to 70.5%, anxiolytics from 14.9% to 21.9%, hypnotics from 14.5% to 
22.9%, and antidepressants from 31.5% to 50.9%. Prevalence of antipsychotics varied 
between extremes 21.1% and 25.6% [180]. 
Recent randomized clinical trials of novel anticoagulants, including direct thrombin inhibitors 
and factor Xa inhibitors, have demonstrated non inferiority and superiority over warfarin for 
stroke prevention. They are also safer and do not require laboratory monitoring. These novel 
anticoagulants have the potential to replace vitamin K antagonists and even aspirin in 
preventing AF-related stroke. Results are probably still pending for the oldest population and 
the price compared to warfarin may be an issue in nursing homes. The bleeding profile is 
however promising [181-187]. A broad update on this issue is also discussed in a panel of 
specialists in October 2011 on MedScape: Evolving Philosophies: Stroke Prevention in 
Atrial Fibrillation A Review of Recent Clinical Trial, 
(http://www.medscape.org/viewarticle/750011?src=0_mp_cmenl_0). 
Several new studies have been performed which further strengthen ProBNP as a diagnostic 
tool and monitoring tool of heart failure, also in elderly patients. The identified risk by 
elevated ProBNP, whether it's a risk for death or a risk for heart failure hospitalization, lower 
values are better, higher values are worse. There's no question about that. But what we also 
know, based on the data from Val-HeFT, is that while a single measurement is useful, serial 
measurements seem to inform even better prognostic value [119-121]. This also refers to 
patients above 75. A panel of experts has discussed these issues at MedScape newly: Guiding 
Heart Failure Therapy: An Update on the Role of Biomarkers, 
(http://www.medscape.org/viewarticle/743110?src=0_mp_cmenl_0). 
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Performing a PubMed search  (Abstract contains "Structured electronic medical records" or 
any field contains "structured EPR" or any field contains "structured EMR" and year contains 
"2012") reveals 67 articles of which only 15 is considered relevant to this thesis [166, 188-
201]. All in all the review confirms the impression of our and earlier research which shows 
positive results of structuring clinical information, however not forgetting the cautions 
mentioned earlier. 
When it comes to the issues of guideline adherence, quality of drug prescriptions among 
elderly and need for quality improvement methods, several studies the last years confirm the 
views presented in this thesis [202 - 215]. 
Conclusions 
Conclusion on primary objectives 
A 12 months intervention with the tested structured electronic medical record system and the 
selected alarms and population lists reduced proportion patients not weighed last 30 days, 
seemed to increase the proportion patients with atrial fibrillation getting warfarin and 
reducing the proportion patients using neuroleptics. All improvements were significant in our 
study, but material was too small for firm conclusions. 
Conclusions on secondary objectives 
There are research results available to show that structured electronic patient records can 
produce faster data recording, higher quality, and notes that are satisfactory for day-to-day 
clinical use. Concerns about unforeseen consequences however also exist. 
The structured electronic patient record system with decision support we tested can easily be 
installed for use in nursing homes and user satisfaction is high. Controlled studies on a 
broader specter of clinical and administrative parameters should be performed. 
Monitoring diagnoses and admission rates to hospitals from nursing homes can give a sound 
basis for evaluating different aspects of running nursing homes. To record “nursing home 
patient” in the hospital electronic medical record at admission would enlighten research. 
Optimal treatment of pneumonias in nursing homes may play a role to reduce pressure on 
medical departments. Solely increasing physician coverage in nursing homes will probably 
not reduce the number of hospitalizations. 
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There are differences in treatment with psychoactive drugs between nursing homes. 
Treatment differences also exist between patients with/without cognitive impairment but 
reasons remains unclear. Improvement strategies and more research are needed. The 
proportion of patients per institution on selected drugs can serve as a feedback parameter in 
quality systems but adding DDDs increases differences. 
Long-term patients with atrial fibrillation and heart failure in nursing homes are treated 
inadequately and/or dissimilarly. Strategies are needed to improve quality of cardiovascular 
treatments. Data on patient consequences of these differences are not present. Recording the 
irregular patient pulse by nurses and doctors and measuring ProBNP regularly may improve 
this. ProBNP levels in nursing home patients are probably not seriously biased by patient 
weight, age and renal function at levels above 225 pmol/l. 
A theoretical possibility exists that structured medical records may produce valid quality and 
production parameters which has been lacking in NPM administration of healthcare. 
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Hospital admissions from nursing homes have not previously been investigated in Norway. During 12 months all hospital
admissions (acute and elective) from 32 nursing homes in Bergen were recorded via the Norwegian ambulance register. The
principal diagnosis made during the stay, length of stay, and the ward were sourced from the hospital’s data register and data
were merged. Altogether 1,311 hospital admissions were recorded during the 12 months. Admissions from nursing homes made
up 6.1% of the total number of admissions to medical wards, while for surgical wards they made up 3.8%. Infections, fractures,
cardiovascular and gastri-related diagnoses represented the most frequent admission diagnoses. Infections accounted for 25.0% of
admissions, including 51.0% pneumonias. Of all the admissions, fractures were the cause in 10.2%. Of all fractures, hip fractures
represented 71.7. The admission rate increased as the proportion of short-term beds increased, and at nursing homes with short-
term beds, admissions increased with increasing physician coverage. Potential reductions in hospitalizations for infections from
nursing homes may play a role to reduce pressure on medical departments as may fracture prevention. Solely increasing physician
coverage in nursing homes will probably not reduce the number of hospitalizations.
1. Background
It is expected that nursing homes will play an important role
in health care delivery in the years ahead. The population
is growing older, and the patients admitted to hospitals are
being discharged earlier. A Norwegian white paper states
that reform is needed to the collaboration between primary
care and hospitals [1]. The growth in costs and utilization
of hospitals is not sustainable. Among several proposals,
the white paper points to accomplishments involving early
discharges from hospitals to nursing homes, which oﬀer
structured rehabilitation programmes. Evaluations have
shown a reduction in mortality, readmission, and later need
for home care for elderly patients [2]. Palliative units in
nursing homes have also been a success [3].
On the other hand, little research has been done on
admissions from nursing home to hospital. There are no
studies in this field from Norway [4]. Internationally, a
correlation has been found between the lack of documented
decisions on the level of treatment and the increase in
admission rate [5]. Clear documentation in logs and records
concerning hospital admissions and heart-lung do-not-
resuscitate decisions can prevent unnecessary admissions.
Acknowledged routines currently in place to treat terminal
patients (Liverpool Care Pathway) may be important tomake
these decisions easier in nursing homes [6]. We also know
that information gaps commonly occurwhen elderly patients
are transferred from a nursing home or seniors’ residence to
the hospital [7].
Norway has 4.6 million inhabitants, 55 public hospitals,
41,052 nursing home beds, and 1,796 beds in old people’s
homes, 96.8% of nursing home beds are in single rooms, and
43,3% of all deaths (total 41,342) are in nursing institutions
[8]. The healthcare system is split in first- and second-
line services. The second line contains the 55 hospitals
and specialist services (included private specialists). Second
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Figure 1: Size and proportion of long-term and short-term beds
in all 32 nursing homes in the city of Bergen (250 000 inhabitants),
Norway. The red part indicates short-term beds (3-4 weeks stays)
and the blue part long-term beds (permanent stays).
line is administered and financed directly from the state.
First-line services are administered and financed by the
municipalities (N = 431). First line covers general practice
(GP) services, mother and child care, home care, and nursing
homes (N = 900).
The study was approved by the Norwegian Social Science
Data Services.
This study investigates the incidence of hospitalizations
from nursing homes, the major diagnostic reasons, what
burden these hospitalizations represent for the main hospital
departments, and what impact manpower and short- to
long-term bed ratio have.
2. Materials andMethod
In 2007, the Norwegian city of Bergen had approximately
250,000 inhabitants and in total 32 nursing homes (2,300
beds, including 300 short-term beds), see Figure 1. Long-
term beds are for permanent residents, mostly until their
death. Short-term beds are mainly for 3-4 weeks rehabilita-
tion stays after hospitalization. In nursing homes in Bergen,
about 50% of physician services are performed by doctors
in permanent positions and the rest by GPs in part-time
positions.
During the period from March 2006 to March 2007
(12 months), all hospital inpatient admissions from nursing
homes in the Municipality of Bergen to the primary and
referral hospital were recorded (the two only hospitals
in Bergen). This was done by searching the ambulance
service’s register of transports from nursing home addresses
to the two hospitals. These patient transports were then
compared with the hospitals’ case history registers to find
ward, diagnoses (ICD-10), and length of stay. The ambulance
register was the only complete source to find fairly complete
figures on hospitalizations from nursing homes for this
retrospective study. To search more information about each
patient from the hospital records was beyond the scope of
the study. Calculations are based on the principal diagnosis.
Information about physician manpower, number of total
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Figure 2: Age distribution of patients admitted to hospital from
nursing homes in the city of Bergen, Norway, during the period
from March 2006 to March 2007 (N = 1311).
beds and number of short-term beds was gathered from the
county health administration.
Two hospitals are delivering hospital services to the
city and surrounding municipalities. Bergen population
represents 62.5% of the total population served by the
hospitals (population 400 000).
There is only one, public, ambulance service in Bergen.
Close to 100 percent of admissions from nursing homes
to the hospitals are made by means of ambulance. All
transports, patient name, transport addresses, and key
medical observations are registered in a database.
Linear regression analysis was used to relate admission
rates for the nursing homes to the proportion of short-term
beds and the proportion of explained variation in admission
rates expressed by the determination coeﬃcient (R2). For
analyzing data, we used Excel and JMP 8.
3. Results
Altogether, 1,311 hospital admissions were recorded during
the 12 months. We found a primary diagnosis in 1185 of
the cases. The number of admissions was 800 (61.0%) to
medical wards (ex pulmonary ward), 385 (29.4%) to surgical
wards, 58 (4.4%) to the pulmonary ward, 39 (3.0%) to the
neurological ward, and 29 to other wards (2.2%).
The age distribution is shown in Figure 2. 959 (73.2%)
patients were at least 80 years of age. Total number of age-
specific hospital bed days compared to hospital bed days
among nursing home patients is presented in Table 1. Age
specific hospitalization rates for total Norway compared to
rates among nursing home patients is presented in Figure 3.
The diagnoses from hospital stays are presented in Table 2
for the medical and surgical wards. Infections, fractures, and
gastrointestinal and cardiac diagnoses stood out as the most
frequent reasons for admissions.
The average length of stay was 4.3 days. There was no
significant diﬀerence between the average length of stay on
medical and surgical wards. A total of 497 (38.0%) of the
admissions had a duration of only one inpatient day.
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Table 1: Total number of age-specific hospital bed days (all
departments and all diagnoses) in the Western Health Region of
Norway as compared to hospital bed days among nursing home
patients.
Age groups
Bed days in hospital per
1000
0–15 years 401.90
16–49 years 383.33
50–66 years 898.16
67–79 years 2427.20
80 years and above 4322.56
All ages 816.83
Nursing home patients within hospitals’
responsibility regions.
3531.30
(Source: Statistics Norway).
Table 2: The generic groups for admissions to medical and surgical
wards from nursing homes in the city of Bergen, Norway, from
March 2006 to March 2007 (N = 1185 with diagnosis).
Medical
ward
Surgical
ward
Total
As % of
admissions
(N = 1185)
Fractures 9 125 134 11.31
Gastric 91 42 133 11.22
Cardiac 121 2 123 10.38
Infections 267 34 301 25.40
Pulmonary 59 0 59 4.98
Nephrological 23 10 33 2.78
Neurological 69 1 70 5.91
Tumour/cancer 21 27 48 4.05
Urinary tracts 3 66 69 5.82
Other 138 78 215 18.22
Total 801 385 1185 100
Of all the admissions (1,311), infection diagnoses repre-
sented 328 (25.0%). Pneumonias and suspected pneumonias
represented 51.0% of infections and 12.8% of all admissions,
Figure 4. The incidence of hospitalizations caused by infec-
tion was 138/1,000 nursing home beds per year.
Fractures were the second most frequent cause counting
134 (10.2%) admissions. Institutions with high fracture rate
could have low infection rate and vice versa. The types of
fracture are as described in Figure 5. Hip fractures repre-
sented 94 (71.7%) of fractures and were the commonest.
After excluding the smallest institutions (less than 30 beds)
due to probable patient diﬀerences, we found a variation
in fracture incidence from 0 to 16/100 patient years, the
average being 6.4. Only one institution had no fractures. The
incidence of fractures treated in hospital among the total
population was 5.6/100 patient years during the 12 months
under review.
The total number of admissions to medical wards in the
two actual hospitals is approximately 21,000 a year, while
to surgical wards it is 16,000 admissions [9]. Bergen city
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Figure 3: Hospitalization rates (per 1000 inhabitants/residents) for
total Norway (N = 4.6millions, age ≥80 years) and among nursing
home patients (N = 2300, long- and short-term, average age appr.
85 years), 2007, in Bergen, Norway. (Source: Statistics Norway).
represents 62.5% of the total hospital responsibilities. The
800 admissions from nursing homes to the medical wards
thus made up 3.8% (6.1% assuming the hospitalization rates
from other municipalities had a similar rate) of the total
number of admissions. This represented 3440 (5508) bed
days calculated on the basis of the average length of stay. For
surgical wards the admissions counted for 2.4% (3.8%) and
1656 (2614) bed-days.
Number of beds in the nursing homes ranged from 20 to
189. 17 institutions had only long-term beds. The percentage
of short-term beds among the 15 mixed homes (long-
and short-term beds) ranged from 7% to 92%. Physician
manpower ranged from 0.16 to 2.12 hours per bed per
week. Linear regression analysis showed a significantly higher
admission rate for nursing homes with a high proportion
of short-term beds than those with a low proportion (R2 =
0.55, P = .0016) and also a tendency to higher admission
rates as a result of increased physician manpower, see
Figure 6. Average physician coverage was 0.48 hours per bed
per week, which significantly positively correlated with the
percentage of institutional short-term beds.
4. Discussion
The incidence of hospitalizations from nursing homes was
570 per 1000 nursing home beds per year. Hospitalizations
(age specific) from nursing homes were less than from
the general population. Admissions from nursing homes
made up 6.1% of the total number of admissions to
medical wards while for surgical wards they made up 3.8%.
Infections, fractures, cardiovascular and gastri-related diag-
noses represented the most frequent admission diagnoses.
Infections accounted for 25.0% of admissions, including
51.0% pneumonias. Of all the admissions, fractures were the
cause in 10.2%. Of all fractures, hip fractures represented
71.7%. The admission rate increased as the proportion of
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Figure 4: Types of infections on admission from nursing home to
hospital in Bergen, Norway, during the period from March 2006 to
March 2007 (N = 328).
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Figure 5: Types of fractures on admission from nursing home to
hospital in Bergen, Norway, during the period from March 2006 to
March 2007 (N = 134).
short-term beds increased, and at nursing homes with short-
term beds, admissions increased with increasing physician
coverage.
5. Limitations of the Study
The role of nursing homes in the delivery of social and health
care services diﬀers between, as well as within, countries.
Nursing homes in many countries are managed as a part
of social care. In Norway nursing homes are regulated as
a health care service. These diﬀerences may influence the
health issue landscape and the composition of staﬀ. Thus,
comparisons and generalizations based on our findings
should be done with care.
We estimated that close to 100% of the admissions from
nursing homes take place using the ambulance service and
therefore considered the basic material reliable. However,
it contains no information about the degree of general
debilitation or the degree of dementia. This is a weakness.
It is diﬃcult to decide whether or not the admissions were
unnecessary. The material is too superficial for that. An
indication of comorbidity is given by numbers of secondary
diagnosis, which range from 0 to 9, averaging 2.9. Our project
had access only to anonymous data and could not count
readmissions, therefore. This strengthens the material from
a patient and data security perspective but calls for further
research.
6. Reasons for Admissions to Hospital
All have the same right to proper medical treatment in
hospitals independent of age. For some old and fragile
patients in nursing homes, however, being hospitalized may
represent a burden [4]. Both from a patient and society
perspective, it may be worth examining ways to reduce
hospitalizations for some nursing home patients.
It has previously been shown that infections are the
most common causes of hospital admissions from nursing
homes [10–12]. This is confirmed by our results. Most
frequent infections in nursing homes have been urinary tract
infections (28–41%), respiratory tract infections (25–32%),
and skin/soft tissue infections (17–19%) [10, 13–16]. Among
hospital admissions we found that urinary tract infections
account for 16.5% of infections and pneumonias for 51.2%.
One measure that may reduce infection admissions is to
ensure that current knowledge about vaccination against
influenza and pneumococcal infection is put into practice.
Modern nursing homes with small wards may reduce the
infection rate of contagious infections, but we found no stud-
ies where the impact of these measures on hospitalization
rates from nursing home residents has been tested. To reduce
hospitalizations due to infections, it is important to secure
qualified staﬀ and necessary equipment in nursing homes.
Intravenous drug and fluid treatment is needed. Mobile X-
ray units can serve several municipalities/nursing homes
[17].
Two studies showed that hip fractures had an incidence
rate of 3.1% per year among nursing home residents with
an average age of 85 [18, 19]. We found a yearly rate
of 4.0% but with considerable diﬀerences among nursing
homes. With regard to measures to prevent fractures, we
know that the potential benefit of hip protectors in reducing
hip fractures in nursing home residents requires further
confirmation [20, 21]. So far Vitamin D supplement seems
to give some fracture protection [22]. The great variation
in admissions for hip fractures among the institutions,
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Figure 6: (a) Admissions correlated to physician hours per bed per week (N = 32,R2 = 0.24, P = .0041, y = 0.4396x+0.4549), grey line with
two institutions with high number of short-term beds and extra staﬃng excluded. (b) Admissions correlated to short-term/long-term beds.
Institutions with zero short-term beds excluded from analysis. Grey line with one institution with almost only short-term beds excluded.
(N = 15, R2 = 0.55/0.04, P = .0016/0.51, y = 1.6074x + 0.2488 for grey line). Dotted lines are confidence curves for regression lines. The
grey circle represents institution 32 (92% short-term beds), and the grey triangle represents institution 31 (43% short-term beds).
including institutions of comparable size and manpower,
should be examined in more detail. This may provide
more knowledge about fracture prevention and diﬀerences
in hospitalization practice. More diﬀerentiation in the use
of psychoactive drugs for patients at risk of falling could
prove valuable like patients with/without the ability to walk
unaided.
7. The Influence ofManpower
Varying results exist as to the impact the number of nurses
has on the frequency of hospital admissions [13, 23, 24].
A retrospective study of 6,623 nursing home patients found
that increasing the proportion of nurses cuts the number of
short-term patient readmissions, but there was no diﬀerence
for long-term patients [25]. This seems logical as more
manpower makes more advanced treatment possible.
We found a correlation in the number of admissions
from increased physician manpower, with the exception of
admissions due to fractures. The need for hospitalization
for fractures is probably obvious for all types of health
personnel, while many other diagnoses are dependent on
diagnostics done by a physician. For example, a study
found an increase in the incidence of infections associated
with increased physician coverage [24]. An increase in
physician manpower in nursing homes might thus have two
diﬀerentiated eﬀects and be dependent on the composition
of diagnoses and the level of diagnostics at the outset.
The admission rate will increase for problems better suited
to hospitalization and decrease for problems best treated
by physicians in the nursing home. Our finding, then,
that a higher level of physician manpower was associated
with an increased number of admissions may indicate
general understaﬃng of physicians in nursing homes. That
increasing proportions of short-term beds leads to increased
number of admissions correlates to our expectations. Short-
term patients are often still in active treatment relationships
with hospital departments and thus probably more frequent
readmissions.
55 peer-reviewed articles on interventions that can
potentially reduce hospitalizations from formal long-term
care settings show the strongest potential for increasing
skilled staﬃng, especially through physician assistants and
nurse practitioners [26].
8. Conclusions
Monitoring diagnoses and admission rates to hospitals from
nursing homes can give a sound basis for evaluating diﬀerent
aspects of running nursing homes. To record “nursing
home patient” in the hospital electronic medical record at
admission would enlighten research. Optimal treatment of
pneumonias in nursing homes may play a role to reduce
pressure onmedical departments. Solely increasing physician
coverage in nursing homes will probably not reduce the
number of hospitalizations.
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Aims: We wanted to pinpoint any differences in treatment between participating
nursing homes, investigate which drugs are currently prescribed most frequently for
long-term patients in nursing homes, estimate prevalence of administration for the
following drug groups: neuroleptics, antidepressants, antidementia agents, opioids
and the neuroleptics/anti-Parkinson’s drug combination, and study comorbidity cor-
relations. We also wanted to study differences in the administration of medications to
patients with reduced cognitive functions in relation to those with normal cognition.
Methods: Information about 513 patients was collected from seven nursing homes in
the city of Bergen, Norway, during the period March–April 2008. This consisted of
copying personal medication records, weighing, recording the previous weight from
records, electrocardiography, anamnestic particulars of any stroke suffered, recording
if there is cognitive impairment or not and analyzing a standardized set of blood
samples. Results: Considerable treatment differences existed between nursing
homes, both percentage patients and Defined Daily Dosages. Patients with reduced
cognitive functions were prescribed less drugs in general, except neuroleptics. Of all
patients, 41.5% were given antidepressants, 24.4% neuroleptics, 22.0% benzodiaze-
pines, 8.0% anticholinesterases and 5.0% memantine. The ratio of traditional to aty-
pical neuroleptics was 122:23. In all, 30.0% of the patients taking neuroleptics were on
more than one drug and 35.0% of the patients had opioids by way of regular or as-
needed drugs, ratio 14.6%:28.7%. Of 146 patients on neuroleptics, five patients had
anti-Parkinson’s drugs too. The average use of regular drugs for patient with intact
cognition was 7.1 drugs, and for patients with reduced cognitive functions 5.7 drugs.
Conclusions: There are differences in treatment with psychoactive drugs between
nursing homes. Patients with reduced cognitive functions receive less cardiovascular
drugs than patients with normal cognition. The reason for this still remains unclear.
Improvement strategies are needed. The proportion of patients per institution on
selected drugs can serve as a feedback parameter in quality systems.
Key words: drug safety; health care quality assessment; health care quality
indicators; management quality circle; nursing homes; pharmacoepidemiology
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Background
Norway has 4.6 million inhabitants, 55 public
hospitals, 41 052 nursing home beds and 1796 beds
in old people’s homes, 96.8% of nursing home
beds are in single rooms and 43.3% of all deaths
(total 41 342) are in nursing institutions (Statistics
Norway, 2010). The health care system is split in
first- and second-line services. The second line
contains the 55 hospitals and specialist services
(included private specialists). Second line is
administered and financed directly from the state.
First-line services are administered and financed
by the municipalities (n5 431). First line covers
general practice services, mother and child care,
home care and nursing homes (n5 900).
The high consumption of psychopharmaceu-
ticals in nursing homes has been emphasized in a
number of studies and the prevalence of psy-
choactive drugs has been well documented earlier,
but some years ago (Ruths et al., 2001; Ranhoff and
Brors, 2005; Selbaek et al., 2008). Few authors have
placed the emphasis on treatment differences
between nursing homes and the general differences
in medication of patients suffering dementia as
opposed to non-demented nursing home patients
(Nygaard et al., 2003).
The high drug consumption among elderly
people over 65 is problematic. On average, the
elderly nursing home residents in Bergen had five
drugs each some years ago (Nygaard et al., 2003).
In a study of drug consumption at five smallish
nursing homes in Norway, drug consumption was
found to be greatest within drugs for ‘digestive
organs and metabolism’, ‘blood and blood-forming
organs’, ‘heart and circulation’, ‘urogenital system
and sex hormones’ and ‘nervous system’ (Nygaard,
2001).
Polypharmacy has usually been defined as
the use of five or more drugs (Hunska˚r, 2003).
Polypharmacy is the most important risk factor
for drug side effects and increases the risk of drug
interactions (Fastbom, 2001; Johnell and Klarin,
2007).
The elderly are particularly vulnerable to the
side effects of psychopharmaceuticals, and antic-
holinergic burden involves a risk of delirium
(Turnheim, 2000). Use of long-acting benzodia-
zepines can be one of the causes of falls in
patients over 65 years of age (Blain et al., 2000).
Concurrent use of three or more psychopharma-
ceuticals has been found to be associated with the
risk of falling (Gales and Menard, 1995).
In the BEDNURS (The Bergen district nursing
home) study, 23% of the patients suffering from
dementia, nursing home population in Bergen,
Norway, were found to be on antipsychotics (Ruths
et al., 2001). Double-blind studies have shown little
symptom reduction connected with the use of anti-
psychotics as compared with placebo (Druckenbrod
et al., 1993; Jeste et al., 2008). Of 27 patients, 23 fare
well or better without antipsychotics (Ruths et al.,
2001). In particular, conventional antipsychotics are
associated with extra pyramidal side effects, like
drug-induced Parkinsonism (Tison et al., 1999; Saltz
et al., 2000). Both atypical and conventional anti-
psychotics are associated with a significantly greater
mortality risk than placebo. The greatest increase in
mortality occurred among people taking higher
(above median) doses of conventional antipsychotic
medications (Wang et al., 2005).
We wanted to pinpoint any differences in treat-
ment between participating nursing homes, investi-
gate which drugs are currently prescribed most
frequently for long-term patients in nursing homes,
estimate prevalence of administration for the fol-
lowing drug groups: neuroleptics, antidepressants,
antidementia agents, opioids and the neuroleptics/
anti-Parkinson’s drug combination, and study
comorbidity correlations. We also wanted to study
differences in the administration of medication
for patients with reduced cognitive functions in
relation to patients with normal cognition.
The study was approved by the Regional Ethics
Committee of Western Norway.
Methods
Bergen has , 250 000 inhabitants and 37 nursing
homes (2300 beds). Bed numbers range from 20
to 189. Seven nursing homes participated in this
study. Participating nursing homes were selected
on the basis of a relative similarity of functions,
county ownership (no private institutions) and
physician staffing. Nursing home characteristics
are presented in Table 1. Only long-term patients
(n5 513) were included. Sufficient information
was available for all patients and they were all
included in the analyses.
Information about the patients was gathered
during the period between March and April 2008.
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Twenty-four medical students conducted the data
collection, which consisted of copying medi-
cation cards (information about drug names, if
regular or as-needed, prescription and dosage),
weighing, details of any stroke suffered and
degree of cognitive impairment. Electrocardio-
graphy was conducted to diagnose atrial fibrilla-
tion and a standardized set of blood samples was
analyzed.
In order to group the material into patients
with/without cognitive impairment, we used the
Berger scale (Berger, 1980) and recorded patient
information. A caregiver who knew the patient
decided between six ‘level descriptions’ of cog-
nitive impairment, thus rating the degree of
severity as a score from 0 to 6. The method was
validated by comparing the extent to which drugs
for dementia were given to patients scoring above
0, giving a 95% overlap.
The recorded data were keyed into Excel and
the drugs were coded according to the Anatomi-
cal Therapeutic Chemical (ATC) Drug Register
(Skrbo et al., 2004). For each drug, the students
punched in the full ATC code, dosage, number
of times per day given, total daily dosage and
whether regular/as-needed. For the psychoactive
drugs, which are part of the comparison between
institutions, Defined Daily Dosages (DDDs) were
registered (except for opioids being part of codine–
paracetamol combination drugs). To compare
the total use of psychoactive drugs (hypnotics,
anxiolytics, antidementia drugs, neuroleptics and
opioids) between institutions, we used the calcu-
lated parameter: [(Drug DDD)3 (% of patients
in institution on drugs of drug-class)]. Straight
counts were performed in Excel, but for statistical
analyses JMP 8 was generally used. Means and
standard deviations (SD) are reported. To analyze
differences in the average between multiple
groups for continuous data, the Tukey–Kramer
(Honestly Significant Difference) multiple com-
parison procedure was used as a parametric
method and the Kruskal–Wallis analysis of var-
iance (ANOVA) as a non-parametric method. For
analyzing ordinal and nominal data, the Pearson
x2 test was used and the results are reported as
odds ratios (OR) with 95% confidence intervals
(CIs). All tests were done at significance level
0.05. To search for factors with potential impact
on prescription rates, we conducted a multinomial
logistic regression analysis, and to adjust for
differences in patient and nursing home character-
istics we performed a two-way ANOVA.
Results
The nursing homes were comparable in terms of
nursing staff (county standard), financing (public,
not private) and residents’ gender distribution
(Pearson x2 test), Table 1. Two institutions had a
significantly lower mean age (Tukey–Kramer) than
the others, nursing homes F and G. Median age was
between 82.7 and 87.3 years for all institutions.
Medications in general
The total number of prescriptions recorded was
3468. The average number of regular drugs was
6.1 per patient (n5 513, SD5 3.3, range: 0–20).
Classified according to principal ATC groups
(Skrbo et al., 2004), the three most frequent were
drugs for the ‘nervous system’, ‘digestive organs and
metabolism’ and ‘heart and circulation’ (Table 2).
Paracetamol was the most frequently prescribed
drug (regular and as-needed) with 5.7% (n5 197)
of the total number of prescriptions (n5 3 468),
administered to 38.4% of the patients.
The average number of as-needed drugs per
patient was 3.8 (n5 513, SD5 2.2, range: 0–14).
Prescriptions of psychoactive drugs by way of
regular or as-needed prescriptions are shown in
Table 3. Of 513 patients, 24.4% (125) were regularly
given one or several neuroleptics, 9.7% (50) of the
patients (n5 513) had neuroleptics by way of an as-
needed prescription and 6.4% (8) of the patients on
regular neuroleptics (n5125) were using two dif-
ferent ones regularly. Risperidone was the most
frequent antipsychotic drug, and haloperidol was
the most frequent as-needed neuroleptic.
Of all, 14.6% (75) of the patients (n5 513)
were on opioids (N02A) by way of regular med-
ication and 28.7% (147) by way of an as-needed
drug, and 41.5% (215) of the patients received
antidepressants as regular medication.
On the basis of our figures, prevalences of long-
term patients in nursing homes being prescribed
psychoactive medication were as follows: neuro-
leptics regular 244/1000 and as-needed 98/1000;
antidepressants regular 419/1000; anxiolytics regular
220/1000 and as-needed 415/1000; and opioids
regular 146/1000 and as-needed 287/1000.
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Table 1 Nursing home characteristics: characteristics of the seven nursing homes with long-term patients participating in the city of Bergen,
Norway, in 2008 (n5513 long-term patients)
Nursing home A B C D E F G Total P
n 83 77 39 85 82 101 46 513
No. of places (total/long/short) 108/88/20 84/63/21 66/31/35 90/90/0 107/81/26 131/99/32 64/48/16 650/500/150
Location in city Suburb Inner city Suburb Suburb Inner city Suburb Suburb
Doctors’ hours per place per week 0.4 0.3 0.5 0.3 0.4 0.4 0.5 0.4 ,0.00011
Men (%) 33.7 33.8 28.2 26.7 21.0 37.6 30.4 30.2 0.27312
Age (years)
Mean 86.7 85.2 84.7 84.9 88.2 79.6 82.2 84.4 0.00013
SD 7.6 10.7 7.5 9.1 6.8 15.7 10.0
Length of stay (days)
Mean 990.0 901.5 973.1 946.1 1728.9 1383.1 1055.2 1171.5 ,0.00014
(6SEM) (6115.8) (6121.8) (6169.0) (6115.8) (117.2) (6106.5) (6169.0)
Median 1102.9 1038.8 747.8 854.7 1071.6 1299.9 873.4
Median test 22.3 21.4 20.5 21.8 4.5 1.0 0.2
Non-demented (%) 20.7 31.6 0.0 29.4 41.4 20.8 19.6 23.4 0.00055
Deviation 23.8 14.7 29.9 13.4 113.2 24.7 22.7
Suffered stroke (%) 29.3 7.9 28.2 34.1 20.7 26.7 13.1 22.8 0.01156
Deviation 14.5 212.1 11.9 19.1 22.2 13.6 24.8
SD5 standard deviation; SEM5 standard error mean.
1 Kruskal–Wallis test.
2 Pearson x2 test.
3–4 Wilcoxon test.
5–6 Pearson x2 test.
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Differences among the nursing homes
We discovered some significant correlations in
the total material that could bias the differences
between nursing homes. Morphine is given less in
the nursing home where the physician was a
specialist (Pearson, P5 0.0097) as were neuro-
leptics (Pearson, P5 0.0139). Neuroleptics were
given more to patients suffering from dementia
(P5 0.0259); fewer benzodiazepines were given
with increasing age (P5 0.0066); the longer the
stay, the fewer the antidementics that were given
(P5 0.0001); and patients on antidepressants
had a lower age (P5 0.0002). However, analyzing
differences among institutions, correcting for
these factors and for age and sex, impacted only
slightly on some P-values, although not on the
total picture.
We discovered significant differences between
nursing homes as a percentage of patients on drugs
within the actual ATC main group. Differences
Table 2 Prescriptions per ATC main groups: ranking of the number of prescriptions according to the classification
of the ATC Drug Register among long-term patients at seven nursing homes in Bergen, Norway (n5513)
Principal ATC group ATC group name No. of prescription %
N Nervous system 1107 31.9
A Digestive organs and metabolism 851 24.5
C Heart and circulation 553 15.9
B Blood and blood-forming organs 389 11.2
R Respiratory organs 140 4.0
H Hormones systemically, without sex hormones and insulin 83 2.4
G Urogenital system and sex hormones 81 2.3
S Sensory organs 80 2.3
M Muscles and skeleton 59 1.7
J Anti-infectants for systemic use 57 1.6
D Dermatological agents 44 1.3
L Antineoplastics and immune modulators 23 0.7
P Antiparasitics 1 0.0
Total number of prescriptions 3468 100.0
ATC5anatomical therapeutic chemical.
Table 3 Psychoactive drugs: ranking of the most prescribed drugs affecting the central nervous system among
513 long-term patients at seven nursing homes in Bergen, Norway
Regular drugs As-needed drugs
ATC code* Drug group Patients
with drug
ATC code Drug group Patients
with drug
n % n %
N06A Antidepressants 215 41.5 N02B Analgesics/antipyretics 227 44.2
N02B Analgesics/antipyretics 206 40.2 N05B Anxiolytics 213 41.5
N05A Antipsychotics 125 24.4 N02A Opioids 147 28.7
N05B Anxiolytics 113 22.0 N05C Hypnotics and sedatives 108 21.1
N05C Hypnotics and sedatives 99 19.3 N05A Antipsychotics 50 9.7
N02A Opioids 75 14.6 N03A Antiepileptics 3 0.6
N06D Antidementics 65 12.7 N06A Antidepressants 3 0.6
N03A Antiepileptics 58 11.3
N04B Dopaminergics (anti-Parkinson’s) 20 3.9
N04A Anticholinergics (anti-Parkinson’s) 9 1.8
N06B Psychostimulants 1 0.2
N02C Migraine drugs 0 0.0
ATC5anatomical therapeutic chemical.
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were highly significant statistically for morphine
(Pearson x2 test, P5 0.0117), neuroleptics
(P5 0.0026) and antidepressants (P5 0.0010),
Table 4. Comparison of drug use among the
patients with reduced cognitive functions by
institution is demonstrated in Figure 1. Differ-
ences between institutions were significant for
neuroleptics (Pearson x2 test, P5 0.0016) and
antidepressants (P5 0.0010) but not for anti-
dementics (P5 0.566).
The addition of DDDs and calculating total
drug use per institution even increased the differ-
ences, and the differences were highly significant for
all drug classes, Table 5 and Figure 2.
Neuroleptics – Parkinsonism
Five out of 18 patients being given drugs for
Parkinsonism were also on neuroleptics. One of
the patients was a psychiatric patient on biper-
iden. One was being given quetiapine, which is an
atypical neuroleptic not contraindicated in the
case of Parkinsonism. Three could be character-
ized as possibly harmful medications. On the basis
of our material, the prevalence of current medi-
cation was 2/1000 among all long-term nursing
home patients.
Medication for patients with impaired cognition
Patients with impaired cognitive function were
prescribed significantly fewer regular drugs than
patients without impairment. The average for
patients without impairment was 7.1 drugs
(n5 130) and for the patients with impaired
cognitive functions 5.7 drugs (n5 381, Wilcoxon
test, P, 0.0001). There was no difference in the
number of as-needed drugs for the two patient
groups. Among patients with impaired cognitive
functions, 21.0% had suffered stroke, and among
patients without impairment 32.0% (OR: 1.76,
95% CI: 1.13–2.75). In general, there was a
tendency to lower the prescription rate of all
cardiovascular drugs for the patients with reduced
Table 4 Institution differences, psychoactive drugs: proportions of long-term patients on one or more regular and
as-needed psychoactive drugs prescribed in seven (A, By) nursing homes in Bergen, Norway, 2008
A B C D E F G P
Morphine regular 0.08 0.13 0.31 0.19 0.18 0.15 0.04 0.0118
Neuroleptics regular 0.36 0.27 0.13 0.32 0.26 0.14 0.15 0.0029
Anxiolytics regular 0.30 0.19 0.26 0.26 0.18 0.23 0.09 0.1111
Hypnotics regular 0.19 0.19 0.18 0.22 0.17 0.19 0.24 0.9677
Antidepressants regular 0.41 0.42 0.49 0.56 0.22 0.40 0.48 0.001
Antidementia regular 0.11 0.14 0.26 0.13 0.07 0.12 0.13 0.2022
Morphine as-needed 0.34 0.27 0.46 0.29 0.34 0.16 0.30 0.0149
Neuroleptics as-needed 0.07 0.08 0.10 0.05 0.21 0.12 0.02 0.0058
Anxiolytics as-needed 0.47 0.42 0.36 0.47 0.30 0.43 0.43 0.3329
Hypnotics as-needed 0.17 0.23 0.23 0.21 0.22 0.23 0.22 0.9644
Antidepressants as-needed 0.00 0.03 0.00 0.00 0.00 0.00 0.02 0.141
Antidementia as-needed na na na na na na na
Figure 1 Use of three different psychoactive drugs
among long-term demented patients at seven nursing
homes (A, By) in Bergen, Norway. Differences between
institutions are significant for neuroleptics (Pearson x2
test, P50.0016) and antidepressants (P50.566). Differences
are not impacted by corrections for age and sex.
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cognitive functions, significantly for angiotensin
converting enzyme inhibitor or angiotensin II
receptor blocker – ACEI/A2B (OR: 1.78, 95%
CI: 1.07–2.94) and diuretics (OR: 1.77, 95% CI:
1.18–2.66). Neuroleptics were more frequently
prescribed to patients with reduced cognitive
functions (31%/21%, OR: 0.58, 95% CI: 0.36–0.94).
ProBNP (brain natriuretic peptide) was signifi-
cantly higher in the patient group without cognitive
impairment (Wilcoxon, P5 0.0011). No such dif-
ferences existed for atrial fibrillation (Pearson x2 test,
P50.137) or renal function (Estimated Glomerular
Filtration Rate, Wilcoxon, P50.1918). Significant
negative correlation was found between age and
weight (Pearson x2 test, P,0.0001), and the average
age among patients with reduced cognitive functions
was lower than the rest of the population (Wilcoxon,
P50.0407). Average patient weight was 62 kg, half
of all patients (n5513) having weight loss last
30 days.
Associations
With regard to comorbidity, we did not find any
associations with the use of neuroleptics and
stroke suffered, or associations between neuro-
leptics and patient weight or weight loss/30 days.
Use of antidepressants was positively associated
with patient weight (Wilcoxon test, P5 0.0037).
No associations for benzodiazepines or hypnotics
were found with stroke, weight or weight loss.
Discussion
The number of drugs given to nursing home patients
in Bergen is higher than the number given 10 years
ago. Considerable treatment rate differences existed
between institutions. Patients with cognitive pro-
blems were prescribed fewer drugs in general but
more neuroleptics. Except for significantly higher
weight in patients on antidepressants, none of the
other clinical factors tested for associations with
psychoactive drugs was significant.
Limitations of the study
The role of nursing homes in the delivery of
social and health care services differs between, as
well as within, countries. Nursing homes in many
countries are managed as part of social care. In
Norway, nursing homes are regulated as a health
care service. These differences may influence the
health issue landscape and composition of staff.
Thus, comparisons and generalizations based on
our findings should be done with care.
For most planned purposes, we consider our
material valid and robust with regard to both
sample size and tested parameters. However, the
size of the material may be too small to calculate
the prevalence of rarer diagnoses/drugs. A weakness
Table 5 Total psychoactive amount (DDD): differences of regularly prescribed psychoactive drugs in seven
nursing homes in Bergen, 2008, expressed by the parameter (total DDD per drug class prescribed)3 (per institution
percentage of patients on drugs of actual class)
A B C D E F G P
Morphine 0.07 0.34 5.21 0.33 0.62 0.34 0.17 ,0.0001
Neuroleptics 4.02 2.76 0.72 9.69 3.06 0.66 0.86 0.0034
Antidepressants 14.89 21.92 28.57 36.74 4.35 17.42 38.71 0.0001
Antidementia drugs 1.32 1.89 5.14 1.75 0.40 1.24 1.51 0.0071
Anxiolytics 2.86 1.56 5.78 2.38 1.73 1.72 0.28 0.0002
Anotics 1.97 2.79 2.31 4.84 2.02 2.64 5.37 0.0001
DDD5Defined Daily Dosages.
Figure 2 Total use (percentages3Defined Daily
Dosage – DDD) for long-term patients on regularly
prescribed psychoactive drugs in seven (A, By) nursing
homes in Bergen, Norway, 2008. Also see Table 5.
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of our study is that comparisons between diagnosis
and drug treatment cannot be performed.
The simple test we used to decide whether or
not patients had reduced cognitive functions can
be questioned (Berger, 1980). Using Minimal
Mental Score was beyond project resources. Our
method was to a certain degree validated, however,
by comparing the extent to which dementia drugs
were given to patients scoring above 0 (reduced
cognitive functions), giving a 95% overlap, and to a
certain degree by medical record data. We thus
found our method sufficient for the purposes
of the study.
Earlier research
We found good concordance with results from
previous studies in terms of the drug groups most
frequently prescribed (N, A, C, B, R; Nygaard, 2001).
In our material, ATC group G (urogenital system
and sex hormones) was used less than previously
demonstrated. References to the use of these drugs
are some years old, and drugs and diagnostics have
evolved, which is probably the reason for this.
The proportion of patients taking neuroleptics
was slightly higher than previously demonstrated
in Bergen nursing homes (23%, 2001). The
decreasing use of neuroleptics in nursing homes
discussed by other authors has not been verified
(Ruths et al., 2001). This is surprising, given
research showing the lack of effect of neuroleptics
among patients suffering dementia. Neuroleptics
are needed in nursing homes, but for limited periods
and for individual patients, and more often than is
currently the case. Patients often end up with a
regular prescription without any evaluation of the
need to pause treatment and take stock after a
period of time (Selbaek et al., 2008).
The use of neuroleptics for patients with Par-
kinson’s is low because of the low prevalence of
Parkinson’s (5.5%); however, the number of these
patients with a drug combination that includes
neuroleptics that are contraindicated is probably
not negligible.
In our study, the prescription of antidepressants
was similar to a comparable study in Bergen in
2001 (Ruths et al., 2001). An increase was
expected. The selective serotonin reuptake inhi-
bitor drugs (SSRIs) are important drugs for the
elderly. Even in our study, we found a positive
association between SSRI use and patient weight.
However, interactions with certain drugs (anti-
epileptics, neuroleptics, cimetidine and codeine)
do exist and they increase the risk of bleeding for
patients on warfarin without impacting the
International Normalized Ratio. Non-steroidal
Anti-inflammatory Drugs together with SSRIs
increase the risk of gastrointestinal bleeding (Van
Der Steen et al., 2009).
Weight gain during antidepressant treatment
can be either a sign of improvement in patients
who have weight loss as a symptom of depression
or a drug side effect. However, significant weight
gain during the acute phase of treatment or
weight gain that continues despite achieving full
remission of depressive symptoms is likely to be
a side effect of antidepressant treatment. Weight
gain is a relatively common problem during both
acute and long-term treatment with antidepressants
(Fava, 2000). In our material, the average patient
weight was 62 kg, half of the patients suffering
weight loss. The unwanted side effect by anti-
depressants in a common population may be an
advantage among nursing home patients. More
research is needed to shed more light on this issue.
However, in our study, the lower age among
patients with reduced cognitive functions may to a
certain degree explain the higher weight in this
group, as weight decreased by age, significantly.
The hazard from falls and fractures when on
psychoactive drugs is well known (Gales and
Menard, 1995; Kiel et al., 2007). In Norway,
, 9000 hip fractures (50% among persons . 85)
are treated in hospitals, giving a yearly age-
independent incidence of 2/1000 and for the
population . 85 , 9/1000 (Van Der Steen et al.,
2009). In Bergen, yearly 90 hip fractures among
2300 nursing home beds were registered over 12
months, 200622007, giving an incidence of 39/1000
(Kru¨ger et al., 2011). The prevalence of hip
fractures has also been estimated by other authors
(Dobnig et al., 2006; Kiel et al., 2007). More differ-
entiation in the use of psychoactive drugs for
patients at risk of falling could prove valuable, like
patients with/without the ability to walk unaided.
A lower cardiovascular drug consumption by
nursing home patients suffering reduced cognitive
functions has been reported by others (Nygaard
et al., 2003). This may reflect a selection effect
as the majority of nursing home patients are
admitted because of dementia (75–80%), and
the others due to somatic illnesses, for example,
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cardiovascular diseases. However, general cardio-
vascular risk factors are also risk factors for devel-
oping Alzheimer’s disease and the combination of
cerebrovascular and degenerative causes make up a
large proportion of all dementias. That ProBNP was
significantly higher among patients without cogni-
tive impairment indicates that morbidity differences
may exist between the two groups, in nursing homes,
with regard to cardiovascular disease. In contrast,
no such differences existed for atrial fibrillation or
renal function. The reasons for lower treatment rate
among patients in nursing homes with impaired
cognitive functions still remain unclear.
Differences between nursing homes
In our study, we have tried to evaluate the
present status and have demonstrated sizable
differences between the nursing homes when it
comes to the use of medications, which cannot be
explained by different prevalences alone. This
was evidenced by our own research on the asso-
ciation between atrial fibrillation and stroke and
warfarin, and it is logical to assume that it obtains
for psychoactive drugs as well (same material,
different publication). Drug differences and phy-
sician staffing have been indicated (Kersten et al.,
2009), but the reasons for such differences are
probably multifactorial, as is quality in general.
Both employee skills and attitudes probably play
a role, as do management, routines, tracking sys-
tems and a collaborative work climate. We did not
see any bias because of sex, age and staffing dif-
ferences between nursing homes or when block-
ing other potentially biasing factors discovered by
multiple regression analysis. Calculating the total
use of drugs within each drug class using DDDs,
increased the differences between institutions,
Table 5 and Figure 1. This probably shows that
institutions with a high percentage use are also
using higher dosages.
Documenting quality status and improving
quality in nursing homes is a challenge. Inter-
nationally, several quality improvement studies
have been undertaken: Nursing homes with a
smaller number of beds, operating for profit and
having a high level of nursing staff may improve
quality (Wan et al., 2006). It has been claimed
that marginalization of physicians in the nursing
home threatens the overall care of increasingly
frail nursing home residents who have medically
complex illnesses (Katz et al., 2009). Medication
quality improvement efforts in nursing homes
should probably focus on the medications com-
monly implicated in errors and should continue to
discourage or closely monitor the use of medica-
tions considered potentially inappropriate in the
elderly (Hansen et al., 2006). A menu-driven
incident-reporting system has the potential to
enhance quality improvement efforts in nursing
homes (Wagner et al., 2005). In pain management,
a multifaceted collaborative intervention proved
valuable, involving audit and feedback on pain
management, education, training, coaching using
rapid-cycle quality improvement techniques and
inter-nursing home collaboration (Baier et al.,
2004). It has been shown that there exists a rela-
tionship between ambitious targets and nursing
home quality (Baier et al., 2009). Implementing
small, focused and inexpensive interventions, like
monitoring BP controls, can improve quality
(Choma et al., 2009).
Simply providing comparative performance
feedback may not be enough to improve resident
outcomes (Rantz et al., 2001). Targeting specific
drugs in the surveyor’s interpretative guidelines
as a method of reducing potentially inappropriate
medication use does not produce the desired
gains in terms of improving the quality of medi-
cation use either (Lapane et al., 2007).
It is difficult to envisage adequate quality con-
trol without the use of modern technology like
medical record systems with alarms, statistics and
decision-making support in addition to already
proven tools for improving the quality of drug
use. The effectiveness of decision support tools
has been shown in several studies and should be
tested in nursing homes (Ornstein et al., 2004;
Kawamoto et al., 2005).
Conclusions
There are differences in treatment with psychoac-
tive drugs between nursing homes. Treatment dif-
ferences also exist between patients with/without
cognitive impairment but reasons remain unclear.
Improvement strategies and more research are
needed. The proportion of patients per institution
on selected drugs can serve as a feedback parameter
in quality systems, but adding DDDs increases
differences.
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Abstract 
Objectives: Previous research suggests that blood-thinning treatment for patients with atrial fibrillation as well as 
treatment for patients with heart failure is not adequate among the elderly. We tested this among long-term patients in 
nursing homes. 
Methods: Information about the patients (n = 513) was collected during the period March-April 2008. Data collection 
consisted of electrocardiography, particulars of any stroke suffered and copying medication records. A standardized set of 
blood samples was analyzed.  
Results: Of the 91 atrial fibrillation patients, 14.3% were anticoagulated with warfarin. 42.0% of the patients with atrial 
fibrillation had no form of antithrombotic treatment. Prevalence of atrial fibrillation was 18.8% and high B-type natriuretic 
peptide (ProBNP > 225 pmol/L) 13.2%. Of the patients with both stroke and atrial fibrillation, 24.3% were given warfarin. 
Of the 59 patients with ProBNP > 225 pmol/L and adequate renal function (eGFR > 50 ml/min), 22.0% were given 
ACE/A2B.  
Conclusions: The warfarin treatment rate was lower than recommended for patients with atrial fibrillation in nursing 
homes, as was probably the use of ACE-inhibitors to heart -failure patients. We found significant differences between the 
nursing homes with regard to treatment rate. Atrial fibrillation and heart failure case finding and monitoring in nursing 
homes needs to be improved and simple tools like recording and reporting irregular pulse by doctors and nurses and 
measure ProBNP on a regular basis may improve this. 
Key words 
Nursing home, Atrial fibrillation, Heart failure, Drugs, Long-term care, Chronic disease 
1 Introduction 
Norway has 4.6 million inhabitants, 55 public hospitals, 41,052 nursing home beds and 1,796 beds in old people’s homes; 
96.8% of nursing home beds are in single rooms and 43.3% of all deaths (total 41,342) are in nursing institutions [1]. The 
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healthcare system is split into first and second line services. First line services are administered and financed by the 
municipalities (N = 431). First line covers general practice (GP) services, mother and child care, home-care and nursing 
homes (N = 900). The second line contains the 55 hospitals and specialist services (including private specialists). Second 
line is administered and financed directly by the state.  
It is expected that nursing homes will play an important role in healthcare delivery in the years ahead. The population is 
growing older and patients admitted to hospitals are being discharged earlier. A Norwegian white paper states that a 
reform is needed to ensure collaboration between primary care and hospitals. After US, Norway (2009) spends the most 
money per capita on health in the world (www.oecd.org), but does not get the most in return for the investments. Poor 
cooperation between first- and second line services is regarded as the main obstacle to improvements [2]. Among several 
proposals, the white paper points to accomplishments involving early discharges from hospitals to nursing homes which 
offer more advanced medical care and structured rehabilitation programs than previously. Quality in the nursing homes 
will thus be under pressure, expectations of services will rise and clinical complexity will grow. New strategies and more 
knowledge about the nursing home population are needed to meet this situation. 
Two of the most frequent diagnoses among the elderly (> 75) are atrial fibrillation (AF) and congestive heart failure. The 
prevalence of AF has not been studied in Norwegian nursing homes, nor has the way AF is treated. The question of 
under-treatment of heart failure in nursing homes has been raised earlier [3]. 
AF is an independent risk factor for developing a stroke [4], and in the elderly it is one of the most important causes of 
stroke [5]. The current guidelines state that most patients over the age of 75 with atrial fibrillation should be anticoagulated 
with warfarin. However, increasing age often leads to lower treatment rate than among younger patients [6, 7]. Stroke risk in 
AF patients can be estimated using the CHADS2 score, which is a clinical prediction rule for estimating the risk of stroke 
in patients with non-rheumatic atrial fibrillation [8]. “Patients are given points on the basis of clinical variables – heart 
failure: 1 point, hypertension: 1 point, over 75 years of age: 1 point, diabetes: 1 point, previous stroke or transient 
ischaemic attack (TIA): 2 points. The annual risk of stroke is: CHADS2 score 0: 1.9%, 1: 2.8%, 2: 4.0%, 3: 5.9%, 4: 8.5%, 
5: 12.5%, 6: 18.2%”. By one (1) point warfarin or aspirin is recommended, by ≥ 2 points warfarin treatment is 
recommended. 
To estimate the risk of bleeding for AF patients on warfarin treatment, bleeding risk scores can be used [9]: “Bleeding risk 
score = 0.49· X (Age >70) + 0.32· X (Female) + 0.58· X (Remote bleed) + 0.62· X (Recent bleed) + 0.71· X (Alcohol/Drug 
Abuse) + 0.27· X (Diabetes) + 0.86· X (Anaemia) + 0.32· X (Antiplatelet), where X equals 1 when the specific 
characteristic is present and 0 otherwise. Bleeding risk scores of > 1.07, > 1.07 but < 2.19, and > 2.19, respectively, are 
classified as low, moderate and high risk. Low-risk individuals have 0.9% bleeding risk, moderate-risk 2.0% and high-risk 
individuals 5.4%”. In the study cited the high-risk bleeding individuals (5.6% bleeding risk) had a 7% stroke risk. 
Simple diagnostic tests are needed in nursing homes to diagnose the most frequent conditions. Transports to hospitals may 
be exhausting for frail and old nursing home patients. Research shows that ProBNP, which is an amino acid secreted by the 
ventricles of the heart in response to excessive stretching of heart muscle cells (cardiomyocytes), provides useful 
diagnostic information supplementary to clinical examination in order to diagnose untreated heart failure in the elderly [10]. 
This refers both to left ventricular function [11] and diastolic dysfunction [12]. To monitor heart failure treatment using 
repeated measurements of ProBNP in blood is probably better than traditional methods like clinical examination and 
echocardiography [13]. 
We wanted to investigate to what degree long-term nursing home residents with AF received antithrombotic treatment and 
to what extent patients with NT-proBNP above 225 pmol/L were treated with angiotensin-converting enzyme (ACE) 
inhibitors/A2 blockers, beta-blockers, statins and diuretics, and to shed light on the biasing effect of renal failure, weight 
and age on ProBNP. We also wanted to study whether there were differences in treatment between the nursing homes. 
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The study was approved by the Regional Ethics Committee of Western Norway. 
2 Materials and methods 
Bergen has 250,000 inhabitants and 37 nursing homes (2,300 beds). The number of beds ranges from 20 to 189. Seven 
nursing homes in Bergen participated in this study. Only long-term patients (n = 513) were included. The nursing homes 
were comparable in terms of nursing staff, financing and gender distribution. 
Information about the patients was gathered during the period March-April 2008. 24 medical students conducted the data 
collection, which consisted of weight, details of any stroke suffered and copying of drug charts. Electrocardiography was 
conducted to diagnose AF and a standardized set of blood samples were analyzed at the laboratory at the Bethany Hospital 
(haemoglobin, B-type natriuretic peptide (ProBNP), sodium, potassium, calcium, albumin, creatinine, blood urea 
nitrogen, urate, estimated glomerular filtration rate (eGFR)). 447 of the patients were blood-tested and 484 ECG’ed. 488 
of the patients were weighed. It was possible to conclude if the patient had undergone a stroke in 462 of the patients. 
Complete medication records existed for all patients. 
We used ProBNP > 225 pmol/L to define patients with heart failure. To understand the degree of the biasing effects of age, 
weight and renal function on ProBNP-levels in this population, we performed bivariate analyses of the factors mentioned 
and quantified explained variation by the determination coefficient (R²). We also estimated non-parametric correlation 
(Spearman’s) between ProBNP and eGFR, as renal function is considered the most important biasing factor for ProBNP. 
To try to find a predictive equation taking all biasing factors into consideration, a multiple linear regression analysis of the 
square root of proBNP on age, weight and the square root of eGFR was performed. 
The recorded data were keyed into an Excel worksheet and the drugs coded according to the Anatomical Therapeutic 
Chemical Drug Register (ATC). Frequency counts were performed in Excel, but the statistical analysis software JMP 
version 8 (from SAS), was used for general statistical analysis. To analyze differences in average of continuous data (e.g. 
ProBNP) the Tukey-Kramer (Honestly Significant Difference) multiple-comparison method was used as a parametric 
method (- assumes that the data has come from a type of probability distribution and makes inferences about the 
parameters of the distribution) and the Wilcoxon test as a non-parametric method (- which do not rely on assumptions that 
the data are drawn from a given probability distribution). Pearson’s chi-square test was used to analyze ordinal and 
nominal data. Results were reported as odds ratios (OR) or relative risks (RR) with 95% confidence intervals (CI), 
estimated directly from 2 × 2 tables. All tests were done at the 5% significance level. 
3 Results 
513 long-term patients residing in seven nursing homes were included. 69% were women, 31% men. The mean age was 
84.1 years. Nursing home characteristics are demonstrated in Table 1 and use of cardiovascular drugs are shown in Table 
2. 
3.1 Atrial fibrillation 
91 (18.8%) of the 484 patients with recorded electrocardiography had AF. There was no significant difference in the 
occurrence of AF among nursing homes (Pearson’s chi-square test: p = 0.4858). 13 (14.3%) of the 91 AF patients were 
anticoagulated with warfarin, 85.7% (78) were not. AF patients were given ASA more than the group without AF (OR = 
1.73, 95% CI: (1.07, 2.78), Pearson’s chi-square test: p = 0.0231). 
There were significant differences in warfarin treatment to AF-patients among nursing homes (from 0 to 50%) as 
demonstrated in Figure 1.  
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The average CHADS2 score for AF patients (91) was ranged from 4 - 6, which corresponds to an annual stroke risk of 
8.5-18.2%. These estimates were based on counting score-giving parameters: Most of the AF patients were older than 75 
years old (87%), giving CHADS2 score “1”. We found that 41% of AF patients had undergone a stroke before, 30% had 
ProBNP > 225 pmol/l, 30% were given ACE inhibitors/A2 blockers, 13% anti-diabetics, 57% diuretics, 23% 
beta-blockers and 12% calcium antagonists, all indicating score-giving illness according to the CHADS2 score. 
 
Figure 1. Percentage of long-term patients with atrial fibrillation (N=91) receiving warfarin in 7 nursing homes (A, B....) 
in Bergen, Norway (Pearson’s chi-square test: p = 0.0391). 
Table 1. Characteristics of the 7nursing homes with long-term patients participating in the city of Bergen, Norway, in 
2008 (N =513 long-term patients) 
Nursing home A  B C D E F G Total P 
N 83 77 39 85 82 101 46 513  
No. of places 
(total/long/short) 
108/88/20 84/63/21 66/31/35 90/90/0 107/81/26 131/99/32 64/18/46 650/500/150  
Location in city suburb 
inner 
city 
suburb suburb inner city suburb suburb   
Doctors’ hours 
per place per 
week 
0.4 0.3 0.5 0.3 0.4 0.4 0.5 0.4  
Men (%) 33.7 33.8 28.2 26.7 21.0 37.6 30.4 30.2 0.273*
Age (years)          
Mean 86.7 85.2 84.7 84.9 88.2 79.6 82.2 84.4 <0.001**
Standard 
deviation 
7.6 10.7 7.5 9.1 6.8 15.7 10.0   
Length (days)          
Mean 990.0 901.5 973.1 946.1 1728.9 1383.1 1055.2 1171.5 <0.001**
Standard 
deviation 
1102.9 1038.9 747.8 849.6 1075.2 1299.9 873.43   
Non-demented 
n=511 (%) 
20.7 31.6 0.0 29.4 41.5 20.8 19.6 23.4 <0.001* 
Deviation (%) -2.7 8.2 -23.4 6.0 18.1 -2.6 -3.8   
Suffered stroke 
n=426 (%) 
32.4 10.2 28.2 35.4 21.5 30.0 15.4 24.7 0.009* 
Deviation (%) 7.7 -14.5 3.5 10.7 -3.2 5.3 -9.3   
*Pearson Chi-square; **Kruskal-Wallis test 
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Table 2. Use of cardiovascular drugs for long-term patients in 7 nursing homes in Bergen, Norway. Left column shows the 
different Anatomical Therapeutic Chemical (ATC) drug groups. For each drug group and nursing home the percentage of 
patients using drugs within the relevant group is shown along with the deviation from the expected average. 
Nursing home     A  B C          D E F G All 
N 83 77 39 85 82 101   46 513         
ATC drug group           
C09, ACE/A2B, ACEI and A2 –blockers (%) 14.46 12.99 17.95 21.18 9.76 17.82 19.57 16.25 
deviation -1.79 -3.26 +1.70 +4.93 -6.49 +1.57 +3.32  
B01A, antithrombotics (%)                 21.69 46.75 43.59 43.53 29.27 27.72 50.00 37.51 
deviation -15.82 +9.24 +3.09 +6.08 -8.24 -9.79 +12.49  
B01A, Albyl (%)                              
 
20.48 
 
41.56 
 
23.8 
 
35.29 
 
24.39 
 
19.80 
 
47.83 
 
30.45 
deviation -9.97 +11.11 -6.65 +4.84 -6.06 -10.65 +17.38  
B01AA03, warfarin (%)                               3.23 3.90 15.38 5.88    0.22   3.96 2.17 4,96 
deviation -1.73 -1.06 +10.42 +0.92 -4.74 -1.00 -2.79  
C03, diuretics (%) 38.55 33.77 48.72 45.88 50.0 25.74 26.09 38.80 
deviation -0.25 -5.03 +9.92 +7.08 +11.20 -13.06 -12.71  
C07, beta-.blockers (%) 13.25 20.78 23.08 24.71 13.41 15.84 19.57 18.66 
deviation -5.41 +2.12 +4.42 +6.05 -5.25 -2.82 +0.91  
C08, calcium channel blockers (%)              7.23 12.99 2.56   9.41  7.32  3.96 8.70 7.45 
deviation -0.22 +5.54 -4.89 +1.96 -0.13 -3.49 +1.25  
120 (23.4%) of the total cohort (N = 513) had at least one incident of stroke. 67 (55.8%) of patients who had suffered a 
stroke received some kind of antithrombotic treatment (ATC = B01A). 10 (8.3%) of these patients were given warfarin. 9 
(24.3%) of 37 patients with both stroke and AF were given warfarin while 27 (73.0%) were given warfarin or some other 
antithrombotic treatment (B01AB/B01AC). 
 
Figure 2. Difference in prevalence (%) of stroke suffered, between patients with AF without warfarin (37/91) as compared 
with patients without AF (78/391) among long-term nursing home patients in Bergen, Norway. (p < 0.0001, 95% CI 
9.74% to 32.27%). 
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Patients with AF not receiving warfarin had strokes significantly more often (37/91 = 40.7%) than those without AF 
(78/391 = 19.9%) (N = 484, odds ratio = 2.75, 95% CI: (1.69, 4.47), Pearson’s chi-square: p <0.0001). Patients with AF 
were 2.75 times more likely to have a stroke suffered than patients without AF (see Figure 2). 
3.2 Heart failure/ProBNP 
59 (13.2%) of the patients had ProBNP > 225 pmol/L. The average ProBNP value for all patients was 112.7 pmol/L (N = 
447, SD 174.8, 95% CI: 96.5 to 129.0). There was no difference in average ProBNP values among nursing homes 
(ANOVA with Tukey-Kramer). Of cardiovascular related drugs, diuretics and heart glycosides were used significantly 
more in patients with ProBNP > 225 pmol/L. Of the 36 patients with ProBNP > 225 pmol/L and adequate renal function 
(eGFR > 50 ml/min.), 8 (22.0%) were given ACE/A2B. The different cardiovascular drugs used in patients with ProBNP 
> 225 pmol/L is presented in Figure 3. 
 
Figure 3. Percentage of patients with ProBNP > 225 pmol/l (N=59) using different heart failure treatments and NSAIDs 
(which are probably contraindicated). 
Comparing the proportion patients using ACE -inhibitor or A2–blocker between the two groups of patients; A, with high 
proBNP (> 225 pmol/L) and adequate renal function (eGFR > 60 ml/min), (7/22) and B; those not having high ProBNP but 
adequate renal function (66/353), no significant difference was found (Pearson’s chi -square test: p = 0.2370). 
Patients younger than the median age (N = 221, 86.5 Years) had an average ProBNP of 77 pmol/L and patients older that 
the median age (N = 225) had an average ProBNP of 145 pmol/L (Wilcoxon p < 0.0001). Patients less than the median 
weight (61.1 kg) had an average ProBNP of 125 pmol/L and patients more than the median weight had an average ProBNP 
= 96 pmol/L (Wilcoxon, p < 0.0001).  
Spearman’s correlation between ProBNP and eGFR was -0.3914 (n = 446; p < 0.001) and doing a linear regression for 
sqrt(proBNP) on sqrt(eGFR) gave the following equation: 
eGFR267237.1457163.19proBNP   
and an R-squared of 0.1234 (see Figure 4). Having adequate renal function (eGFR > 60 ml/min) thus predicted a ProBNP 
< 92.93 pmol/l (= 19.457163 - 1.267237×√60) and eGFR = 12.37 ml/min is the renal function which predicts a ProBNP = 
225 pmol/l (x = ((√225-19.457163)/1.267237)2 = 12.3709014). No patients in our cohort (N = 513) had an eGFR that low. 
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From a multiple linear regression analysis of the square root of proBNP on age, weight and the square root of eGFR we 
found the following prediction equation: 
2)17.1070138.00630223.0651306.17(Pr eGFRweightageoBNP   
For example for an 80-year-old patient weighing 70 kg and having eGFR = 30 the predicted ProBNP is 129.39 pmol/L. 
 
Figure 4. Correlation between ProBNP and eGFR among 446 long-term patients in nursing homes in Bergen, Norway 
(median age 86.5 years, median weight 61.2 kg). Linear regression for sqrt(proBNP) on sqrt(eGFR) gave the following 
equation: sqrt(proBNP) = 19.457163 - 1.267237*sqrt(eGFR) and an R-squared of 0.1234. eGFR 12.37 ml/min. is the renal 
function which predicts a ProBNP = 225 pmol/L (x = ((sqrt(225)-19.457163)/1.267237)¨2 = 12.3709014). eGFR 60 
ml/min. predicts ProBNP 92.93 pmol/L. 
4 Discussion 
The prevalence of AF among long-term nursing home residents was 18.8% (91 of 484 ECG’ed). Of these patients, 14.3% 
(13) were treated with warfarin and 41.8% (38) had no antithrombotic treatment at all. The estimated CHADS2 
score-based annual stroke risk for this AF-population was between 8.5 and 18.2%. Of 36 patients with ProBNP > 225 
pmol/l and adequate renal function, 22.0% were treated with ACEI/A2B. There were significant differences in treatment 
of AF and use of heart failure drugs in patients with ProBNP > 225 pmol/L among nursing homes in the study. 
The role of nursing homes in the delivery of social and healthcare services differs among countries as well as within 
countries. These differences may influence the health issue landscape and composition of staff. Thus comparisons and 
generalizations based on our findings should be made with care. 
5 Limitations of the study 
It may be claimed that using ProBNP as the only parameter to diagnose insufficiently or non- treated heart failure weakens 
the study and most procedures in force recommend echocardiogram to diagnose heart failure. On the other hand, an 
echocardiogram is often impractical as a diagnostic tool for nursing home patients both due to equipment price and 
physician qualifications. Transporting patients to a specialist cannot always be recommended for these frail patients either. 
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The cut-off value of ProBNP as a diagnostic tool for heart-failure in need of treatment, in different populations, is a matter 
of discussion. The high median age in our cohort made us go for a relatively high cut-off value (as increasing age leads to 
increasing ProBNP levels) even though that weakened sensitivity of the test. The main purpose of our study was however 
to examine if under-treatment existed in heart failure patients. Therefore, specificity (the proportion of negatives in the test 
which are correctly identified) was more important than sensitivity (proportion of actual positives which are correctly 
identified). We needed to be fairly sure to exclude healthy patients, missing some sick patients however, strengthens the 
under-treatment conclusion. 
The identified risk by elevated ProBNP, whether it’s a risk for death or a risk for heart failure hospitalization, lower values 
are better, higher values are worse. What one also knows, based on the data from Val-HeFT, is that while a single 
measurement is useful, serial measurements seem to inform even better prognostic value. This also refers to patients above 
75 [14-16].  
Cut-off limits of ProBNP as a diagnostic and prognostic tool in heart failure are discussed in numerous studies. In one 
study (mean age 73 years, followed for 6 years and registering all cardiovascular mortality) persons with ProBNP above 
200 pmol/L had higher mortality [17]. In another study, 24 out of 25 patients were classified correctly with regard to heart 
failure, as compared with cardiac echo, using a ProBNP cut-off of 223 pmol/L [10]. 
Our results of bivariate fits of ProBNP by eGFR, weight and age (which are the known biasing factors), lead us to the 
conclusion that nursing home patients with a ProBNP > 225 pmol/L were more likely to have heart failure and, above this 
level, the high ProBNP values were not caused by high age, low weight or renal failure. 
5.1 Atrial fibrillation 
We found that 18.8% (91) of the patients had AF in our study population. The prevalence of AF has been found to be 17% 
for patients over 65 years and to increase with age [18]. Our prevalence is comparable to earlier findings and age groups. 
Patients with AF, older than 65, have been consistently undertreated with anticoagulants [19]. This is consistent with our 
finding that the warfarin treatment rate was low (14.3%). Even a warfarin treatment rate of about 65% of elderly 
AF-patients is considered problematic by several authors [9, 20]. In our study, we found a significant increase in stroke 
prevalence in AF patients not treated with warfarin, which illustrates under-treatment. Reasons for low treatment rates 
might be fear of intracranial haemorrhage and falls [20] but with systematic monitoring the risks associated with oral 
anticoagulation treatment appears to be low [21]. To start life-prolonging treatments may not always be as obvious to do in 
nursing home patients compared to younger patient groups. Suffering involved with stroke is considerable, however, and 
should be prevented if possible, at all ages. 
Based on our estimates the stroke risk among nursing home residents with AF was 8.5-18.2%, considerably above 5.6% 
which is considered the highest bleeding risk score according to Shireman et al. [9]. Increased risk of bleeding episodes on 
warfarin treatment usually occurs among the elders aged within two months of start-up [22]. On the other hand, increased 
CHADS2 score (4-6) in the oldest (>85) population may increase bleeding risk [23]. Treatment must always be 
individualized therefore. 
McCormick et al. [24] found that AF was present in 429 (17%) of 2,587 long-term care residents. Overall, 42% of these AF 
patients were receiving warfarin. This is consistent with our study when it comes to AF prevalence and more in line with 
our own opinion of a reasonable treatment level of frail nursing home patients than our own findings. 
5.2 Heart failure/ProBNP 
We found 13.2% (59) had a higher ProBNP (> 225 pmol/L). 8-10% was the prevalence rate for heart failure in earlier 
studies [25]. Only ten (16.7%) of the patients were given both ACE/A2B and diuretics, which suggests under-treatment. 
This impression is reinforced by the lack of significant ACE/A2B differences in treatment rates between the patient group 
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with high ProBNP and normal renal function (eGFR > 60 ml/min – giving a therapeutic indication without renal 
contraindication) compared to the rest of the cohort. 
A high proportion of renal failure among the elderly has been considered to engender reservations in prescribing ACE 
inhibitors for this patient group [26]. However, it is not appropriate to withhold ACE inhibitors for heart failure in patients 
with only mild renal failure [27, 28]. Our findings show a low treatment rate in patients with adequate renal function as well. 
6 Improvement strategies 
It has been claimed that the marginalization of physicians in the nursing home is threatening the overall care of 
increasingly frail nursing home residents who have medically complex illnesses [29]. Staffing by trained doctors seems to 
be needed as well as training programs in treatment guidelines for AF and heart failure. Modern technological tools may be 
a way to increase treatment rate of warfarin to AF patients and ACE-inhibitors and A2-blockers to heart failure patients. 
Electronic patient records with reminders (e.g. “this patient has ProBNP > 250 pmol/L and normal renal function but 
receives no ACE-inhibitor or A2-blocker”) have been proven effective in general practice and hospitals [30, 31]. Until now 
such tools have only been used or tested in a limited number of nursing homes [32]. 
7 Conclusion 
Long-term patients with atrial fibrillation and heart failure in nursing homes are treated inadequately and dissimilarly. 
Strategies are needed to improve quality of cardiovascular treatments. Recording the irregular patient pulse by nurses and 
doctors and measuring ProBNP regularly may improve this. ProBNP levels in nursing home patients are probably not 
seriously biased by patient weight, age and renal function at levels above 225 pmol/L. 
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Background. Nursing homes face challenges in the coming years due to the increased number of elderly. Quality will be under
pressure, expectations of the services will rise, and clinical complexity will grow. New strategies are needed to meet this situation.
Modern clinical information systems with decision support may be part of that. Objectives. To study the impact of introducing an
electronic patient record system with decision support on the use of warfarin, neuroleptics and weighing of patients, in nursing
homes. Methods. A prevalence study was performed in seven nursing homes with 513 subjects. A before-after study with internal
controls was performed. Results. The prevalence of atrial fibrillation in the seven nursing homes was 18.8%. After intervention, the
proportion of all patients taking warfarin increased from 3.0% to 9.8% (P = 0.0086), neuroleptics decreased from 33.0% to 21.5%
(P = 0.0121), and the proportion not weighed decreased from 72.6% to 16.0% (P < 0.0001). The internal controls did not change
significantly. Conclusion. Statistics and management data can be continuously produced to monitor the quality of work processes.
The electronic health record system and its system for decision support can improve drug therapy and monitoring of treatment
policy.
1. Background
Nursing homes face challenges in the coming years due to an
increased number of elderly. Quality will be under pressure,
expectations of the services will rise, and clinical complexity
will grow. New strategies are needed to meet this situation.
Modern clinical information systems with decision support
may be part of that.
1.1. Clinical Issues. Based on clinical experience and infor-
mation about 513 long-term patients, we believed that
there could be failure of the blood-thinning treatment of
patients with atrial fibrillation. Likewise, we thought that
weighing procedures were followed up for the poor. Use
of neuroleptics for the oldest patients is under continuous
debate. Therefore, we decided to focus on endpoints within
these fields.
One of the most frequent diagnoses among the elderly
is atrial fibrillation. Atrial fibrillation is an independent risk
factor for developing a stroke [1], and in the elderly it is
one of the most important causes of stroke [2]. The current
guidelines in force are that all over-75s with atrial fibrillation
are to be anticoagulated, but increasing age often produces
the opposite eﬀect with decreased prescriptions to the oldest
[3, 4].
The presence of nutritional failure in Norwegian nursing
homes has been questioned [5]. Little research in the field has
been done so far. There is good evidence showing that inap-
propriate weight loss in the elderly materially impairs their
quality of life and life prospects. The convalescence period
for illness also increases substantially [6]. A significantly
increased risk has been shown for secondary complications
like pressure sores [7], infection, depression, and functional
impairment [8, 9] as well as increased mortality [10–14].
The high consumption of psychopharmaceuticals in
nursing homes has been emphasized in a number of
studies. 23% of the demented nursing home population in
Bergen was found to be on antipsychotics. The prevalence
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of psychoactive drugs has been well documented earlier,
but some years ago [15, 16]. Double-blind studies have
shown little symptom reduction connected with the use of
antipsychotics as compared with placebo [17, 18].
1.2. Decision Support. There are weaknesses involved in
introducing consensus-based therapeutic regimes in a pop-
ulation. Often test results are not followed up. In a meta-
analysis, Kawamoto and colleagues dealt with studies on the
eﬀectiveness of decision-making support tools and found
that 68% of the systems showed significant improvement in
practice [19].
A clinical decision support system (CDSS) is an appli-
cation that analyzes data to help healthcare providers
make clinical decisions. Decision-making support is closely
correlated with structured record information, because the
decision-making support tools have to respond to correct
information in the record—for example, pathological test
results. This is easier to accomplish if the underlying data are
structured and standardized. A number of major European
projects hinge on this issue [20].
The traditional medical approach focuses on the indi-
vidual, with particular emphasis on symptoms, signs and
test results emerging from the encounter with individual
patients. In order to ensure accessible and correct treatment
for all patients, it is also possible to operate using population-
directed control measures, for example, keeping track of
the proportion of a patient population on a specific drug.
This is especially applicable in nursing homes where about
75% of patients are demented and cannot take responsibility
for their own followup. The benefit of population-targeted
intervention has also been proved in several studies [21].
The users’ views on data systems are important for the
real-term prospects of disseminating such tools. Doctors
appreciate structured recording [22, 23]. Nurses’ views on
electronic patient records have been studied at a major
hospital in Florida [24]. Of 100 nurses, one-third felt that
electronic patient records resulted in a reduced workload and
roughly the same proportion preferred being able to provide
documentation at the patient’s bedside, but said that this was
often made diﬃcult. A quarter thought that documentation
was improved and the use of electronic patient records
would improve patient safety. Nurses with experience of
information technology consistently had more positive views
than those without such experience.
In this project, we wanted to study whether decision
support as part of an electronic, structured patient record
system, together with targeted education, could improve the
quality of medical treatment while avoiding negative impact
on job satisfaction among users.
2. Material and Methods
We performed a prevalence study to quantify the proportion
of long-term patients with atrial fibrillation that were being
given warfarin, were taking neuroleptics, and had not been
weighed for the last 30 days. Then, a before-after intervention
study was done. The before-after study was conducted as
a double cross-sectional design. Instead of randomization,
we decided to use the proportion of patients on digitalis,
thyroxin, and antidiabetics as internal controls (participants
exposed to the same study, but these drugs were not part of
any concrete intervention and were unlikely to undergo any
changes by external factors.) [25]. The proportion of patients
on neuroleptics was in addition followed as a time series
(a sequence of data points, measured typically at successive
times spaced at uniform time intervals) [26–28] in two
nursing homes from 23 October 2008 to 15 July 2010.
2.1. Before-Data. The prevalence (before) survey was per-
formed among long-term residents in seven nursing homes
(N = 513). Bergen, Norway has approximately 250,000
inhabitants and 37 nursing homes (2,300 beds). The number
of beds ranges from 20 to 189.
Information about the patients was gathered during the
period March-April 2008. Medical students conducted the
data collection, which consisted of copyingmedication cards,
weighing by means of a local tool, but standardized clothing,
and finding previously recorded weight/date. Electrocardio-
graphy (ECG) to diagnose atrial fibrillation was performed
and a standardized set of blood samples analysed at the
laboratory of the Bethany Hospital. The recorded data were
keyed into Excel and the drugs coded according to the
Anatomic Therapeutic Chemical (ATC) Drug Register.
The nursing homes were selected based on approximately
similar size, function, and public ownership. They were
comparable in terms of nursing staﬀ and financing, but some
diﬀerences existed with regard to other variables (Table 1).
2.2. Intervention. After quantifying clinical issues through
the before-survey, we installed an electronic, structured
patient record system which included decision support. The
system had been developed and operating at Løva˚sen edu-
cational nursing home (developing institution) for several
years, funded by the Norwegian Medical Association and the
Norwegian Research Council. Installation and training were
carried out in the last quarter of 2008, and 6 of the 7 nursing
homes were running the system on a daily basis from January
2009 for 12 months. After the active intervention period, the
number of nursing homes running the system was reduced
to three institutions, owing to contracts between Bergen
Municipality and another vendor having been signed before
the project started. Løva˚sen Nursing Home and two of the
study institutions continued and were the only institutions
available for follow-up data. Data had to be collected directly
from the electronic patient record system.
The technical intervention consisted of population filters
and reminders. The system incorporated filters and alarms
within several areas, but we decided to test 4 filters and
2 reminders. Population filters were predefined filters that
produced lists of patients according to criteria in seconds.
The tested population filters were (a) “patients taking
neuroleptics” (list and proportion), (b) “patients taking
warfarin” (list and proportion), (c) “patients with the
diagnosis atrial fibrillation and their treatment status” (list
and proportion), and (d) “patients not weighed for last 30
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Table 1: Characteristics of the 7 nursing homes in the city of Bergen, Norway, participating (N = 513 long-term patients).
Nursing home A B C D E F G Total P
N: 83 77 39 85 82 101 46 513
No. of places, total/long/short 108/88/20 84/63/21 66/31/35 90/90/0 107/81/26 131/99/32 64/48/16 650/500/150
Location in city Suburb Inner city Suburb Suburb Inner city Suburb Suburb
Doctors’ hours per place per week 0.4 0.3 0.5 0.3 0.4 0.4 0.5 0.4
Men, % 33.7 33.8 28.2 26.7 21.0 37.6 30.4 30.2 0.2731
Age, years
Mean 86.7 85.2 84.7 84.9 88.2 79.6 82.2 84.4 <0.0012
Standard deviation 7.6 10.7 7.5 9.1 6.8 15.7 10.0
Length of stay, days
Mean 990.0 901.5 973.1 946.1 1,728.9 1,383.1 1,055.2 1,171.5 <0.0012
Standard deviation 1102.9 1038.9 747.8 849.6 1075.2 1299.9 873.43
Nondemented n = 511, % 20.7 31.6 0.0 29.4 41.5 20.8 19.6 23.4 <0.0011
Deviation % −2.7 8.2 −23.4 6.0 18.1 −2.6 −3.8
Suﬀered stroke n = 462, % 32.4 10.2 28.2 35.4 21.5 30.0 15.4 24.7 0.0091
Deviation % 7.7 −14.5 3.5 10.7 −3.2 5.3 −9.3
1
Pearson’ chi-square test; 2Kruskal-Wallis test.
Table 2: User survey among employees in 7 nursing homes in
Bergen (N = 272, 54%).
Sex % Age % Position N %
Male 12 <40 34 Nurse 97 37
Female 88 40–54 46 Assistant nurse 91 35
>54 20 Physician 16 6
Other 58 22
days” (list and proportion). Tested reminders visible in each
patient’s record, if the criteria were met, were (a) “patient
has diagnosis of atrial fibrillation but is not on warfarin” and
(b) “patient not weighed for last 30 days.” Figures 1 and 2
demonstrate how this was arranged within the application.
Results from the before-study were presented to the par-
ticipating doctors during the first 12 months of intervention
through three two-hour lectures.
2.3. After-Data. Two institutions (E and F in Table 1)
participated in the after-study. To collect the data we used
the population filters in the medical record system to find the
proportions of patients on endpoint drugs, internal controls,
and patients not weighed for the last 30 days. Before-data
were extracted from the prevalence study for institutions E
and F (N = 183) for the before-after analysis. Institution E
participated with an additional department (22 patients) in
the intervention study (N = 205, after).
To study user satisfaction, we performed an anonymous
survey among the doctors, nurses, assistant nurses, and
physiotherapists (N = 504). Potential respondents were all
users defined in the electronic system. They were invited by e-
mail to respond to an electronic questionnaire. 16 questions
about position and several aspects of their view on the
functionality of the application were presented. Questions
were closed, with a score from 1 to 5 (worse–better). The
Table 3: Results from the user survey among employees in 8
nursing homes in Bergen, Norway, participating testing the “UNO
GBD” electronic patient record system (2008–2010), a structured
medical record system with decision-making support (N = 272,
54%).
(i) 65%—used application on a daily basis
(ii) 81%—exploited reminders when planned the work
(iii) 90%—documentation requirements were met
(iv) 67%—less time consuming
(v) 43%—increased job satisfaction
(vi) 72%—reminders supported them in doing the job
(vii) 83%—application contributed to safer medication
survey was constructed by a group of study nurses from the
institutions, with technical organization by the vendor.
2.4. Statistics. For the prevalence (before) survey, the
recorded data were keyed into an Excel worksheet and
the drugs coded according to the Anatomical Therapeutic
Chemical (ATC) Drug Register. To compare proportion of
populations, Pearson’s chi-square test was used. To com-
pare distribution of continuous variables, Kruskal-Wallis’
nonparametric one-way analysis of variance was performed.
Straight counts were performed in Excel, but JMP 8 was
generally used for statistical analyses.
3. Results
In the prevalence study, all long-term patients in 7 nursing
homes were examined (N = 513). There were no dropouts.
The before-after study included all long-term patients in two
institutions (N = 183 before, 205 after), also no drop-outs.
272 (54%) users responded to the questionnaire, Tables 2 and
3.
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Figure 1: Population filters. How subgroup filters and reports are presented in the UNO GBD patient record system, a structured medical
record system with decision-making support, tested in 7 nursing homes in Bergen, Norway 2008–2010. The blue “menu” is for translation
purposes.
3.1. Before-Survey. In the prevalence study of 484 long-term
patients ECG-ed, atrial fibrillation was found in 91 (18.8%).
No significant diﬀerences existed between the 7 institutions.
Of 91 atrial fibrillation patients, 14.2% were anticoagulated
with warfarin, that is, 2.5% of all patients.
72.6% of all patients were not weighed for the last 30
days. There was an average of 121 days between weight
measurements. Significant diﬀerences were demonstrated
between nursing homes.
Of all patients, 24.4% were taking neuroleptics. 30.0% of
the patients taking neuroleptics were onmore than one drug.
3.2. Before—After. At the two institutions (E and F) partic-
ipating in the before-after study, the proportion of patients
taking neuroleptics was reduced from 33.0% to 21.5% (N =
183 before/205 after, chi-square test, P = 0.015), that is,
a diﬀerence of 11.5% (95% CI: 2.3 to 20.6%). Warfarin
increased from 3.0% to 9.8% (P = 0.013), that is, a diﬀerence
of 6.8% (95% CI: 1.6 to 12.1%). Use of digitoxin did not
increase significantly (8.0% versus 8.5%; P = 0.1), thyroxin
was not reduced (10.0% versus 8.6%, P = 0.765), and
antidiabetics did not increase (10.0% versus 10.5%; P =
0.996), Figure 4. The proportion of patients not weighed for
the last 30 days was reduced from 72.6% to 16.0% (P <
0.001), that is, a diﬀerence of 56.6% (95% (CI: 47.5 to
64.5%).
The time-series for proportions of patients using neu-
roleptics is presented in Figure 3.
In the user survey (n = 272, 54%), 43% reported great or
slightly better job satisfaction. Further results from the user
survey are presented in Table 3.
4. Discussion
Endpoints changed significantly during intervention by
increased use of warfarin, decreased use of neuroleptics, and
a higher weighing rate. Job satisfaction was not adversely
aﬀected.
4.1. Limitations of the Study. The role of nursing homes
in the delivery of social and health care services diﬀers
between, as well as within, countries. Nursing homes inmany
countries are managed as part of social care. In Norway,
nursing homes are regulated as a health care service. These
ISRN Nursing 5
Figure 2: The way “reminders” and interaction warnings are presented in UNO GBD, a structured medical record system with decision-
making support, tested in 7 nursing homes in Bergen, Norway 2008–2010. The grey “menu” is for translation purposes.
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Figure 3: Time-series on the proportion of patients using neu-
roleptics, in 3 nursing homes in Bergen, Norway 2008–2010,
before and during implementation with a structuredmedical record
system with decision support. Blue line represents institution E
(see Figure 1), green line institution F, and red line the developing
institution. Institution E and F were included in the before-after
study. Red arrow indicates implementation startup.
diﬀerences may influence the health issue landscape and
composition of staﬀ. Thus, comparisons and generalizations
based on our findings should be made with care.
The methods for evaluating change and improvement
strategies are not well described. Such study designs should
generally be used in a context where they build on appropri-
ate theoretical, qualitative, and modelling work, particularly
in the development of appropriate interventions [29]. We
feel that we have properly documented the fields in need of
improvement and thus study objectives.
Baseline and follow-up data for the first cross-sectional
sample were collected, by the prevalence study (before) and
(in the case of the second sample) after the intervention,
respectively. As it was not possible to collect follow-up data
for everyone included in the first study (for political reasons)
and the patients included in the second sample were not
identical to those in the first due to deaths, the two samples
were compared using methods for comparing unpaired data.
This is a weakness, but to compensate for the 40% or so
annual death rate in nursing homes, the sample size would
have had to be much higher to be able to use patients as their
own controls, and this may not have been advisable when
testing front-end technology in the first study.
Our design must be seen in light of the immaturity
of research in nursing homes in general. As far as we
know, neither recent data exist on the prevalence of atrial
fibrillation in a nursing home population and the use of
warfarin, nor is information available on how well basic
procedures like weighing are conducted. More information
has been available on the use of neuroleptics. There was
therefore a need to do a prevalence study, to define valid
endpoints, and to do an intervention study. It may be
claimed that we should have separated the tasks, but nursing
homes are in great need of improvement strategies and
time is short before the elderly wave is set to impact
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Figure 4: Changes in endpoints and internal controls in the before-
after intervention study, among long-term patients in 2 nursing
homes in Bergen, 2008–2010. Before and after intervention with
a structured medical record with decision-making support, the
proportion of patients on the drugs was measured (N = 182
before/205 after, chi-square test) Dark blue = Neuroleptics, red =
warfarin, others = internal controls.
heavily on nursing home demands. Financial and political
limitations played a role too, obstructing any possibility
of performing a full-scale follow-up study. But conversely,
it would have been a challenge, in a randomized trial
within one municipality, albeit with 37 institutions to choose
from, to avoid study group pollution and the “Hawthorne
eﬀect” [29, 30]. Starting out with a comprehensive and
expensive randomized study would probably not have been
ethical due to all the uncertainty and possible threats from
new information technology systems, and hence probably
diﬃcult to fund. When we started, we did not know if it was
possible to install the application, educate, and prepare for
critical daily use in 7 institutions with 500 to 800 users within
a timeframe of 4months. Looking back, this may be regarded
as the most convincing result of the project.
4.2. Eﬀects of Integrated Electronic Decision Support. We used
a design where we evaluated endpoints in a before-after
study with internal controls [26–28]. The stability of internal
controls throughout the intervention reinforces the internal
validity of the study.
With the technology presented, eﬀects can be measured
continuously, Figure 3. However, we cannot conclude the
extent to which the technical aspect or “awareness of the
performance process” is responsible, through education, for
the changes measured. Yet without any performance figures,
it is not possible to focus on changing processes, so the two
ways of influencing results are not independent factors.
The technology made it possible to monitor performance
without time-consuming traditional studies and made per-
formance feedback possible. This is a relatively new concept
in medical research, made possible by structured medical
input applicable to automatic and continuous analysis.
Consequently, the proportion of patients taking neuroleptics
could also be followed using time-series, givingmore detailed
information about the changing process and strengthening
the validity of the eﬀect results. As a critical information
element, drugs were punched into each patient record at an
early stage of the implementation process and this gave us
a suﬃcient “before-point” on the time-series. We discovered
that the significant change in the before-after study was due
to only one of the participating institutions and that this
institution showed up a clear brake in the curve at the point
of intervention startup.
4.3. New Possibilities. We see from the time-series on neu-
roleptics (time-series are part of the patient record system)
that the tool also provides a deeper understanding of the
change process. By observing the curves, Figure 3, we learn
something about possible variation in the use of neuroleptics
during the year. This makes one think that performance
feedback, over time, may equal performance around a “total
average” [31]. Other authors have concluded that evaluative
studies should report on usage patterns and progression of
outcomes over time [32]. Very few authors have reported
on feedback at institutional level with performance com-
parisons. At vaccination clinics, however, it has been shown
that performance feedback at institutional level can improve
quality [33]. Logically, this may be one way of influencing
both generalized over- and undertreatment in institutions.
Our own research (same material, and publications to come)
has shown that diﬀerences between comparable nursing
homes do exist, significantly. With regard to both the
proportion of patients using cardiovascular and psychoactive
medications, and weight loss and weighing routines, we
found significant diﬀerences between the 7 nursing homes
participating in the prevalence survey (same study, diﬀerent
publications). We hope to continue our research based on
this feedback method to test if this is a way to increase
equality and quality among a bigger number of institutions.
We are however convinced of the importance of human
attention. Technology is a tool only, without any impact, if
managers and practitioners are not reacting to warnings and
are not exploiting the population filter function!
5. Conclusions
Statistics and management data can be continuously pro-
duced through daily bedside work. The structured electronic
patient record system with decision support we tested
can improve drug treatment and monitoring and better
implementation of procedures. It can easily be installed
for use in nursing homes. Controlled studies on a broader
spectrum of clinical and administrative parameters should
be performed.
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